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To Margaret 
ýýý 
We restore, repair and make whole those parts of the face which 
nature has given but which fortune has taken away, not so much 
that they may delight the eye, but that they may buoy up the 
spirit and help the mind of the afflicted. 
Gaspare Taglacozzi 
AD 1546-1599 
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The whole of the experimentation described in this thesis 
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St. Lukes Hospital, Bradford and the School of Biomedical Sciences, 
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made. The elastomer materials testing was in co-operation with 
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Various silicone elastomers have been evaluated for use in the prosthetic 
reconstruction of facial defects. Their strength, texture, flexibility, 
hardness, ease of preparation, pigment receptivity and retention, and 
their resistance to cleaning were compared and the data consulted when an 
elastomer was chosen to restore defects, improve aesthetics and re- 
establish the confidence of a selection of patients. Detailed case 
reports are provided, together with information on the adhesives or 
mechanical methods available for retaining the facial prosetheses. 
Cyanoacrylate adhesives for use on skin surfaces and as tissue adhesives 
have been studied in detail. A novel n-butyl 413 cyanoacrylate has been 
developed with a viscosity, haemostatic property and stability to make it 
particularly suitable for use in skin grafting and tissue repair. It has 
already been used with good results on patients with severe burns. An 
improved formulation, containing a fluorescent dye, can be precisely 
applied through a specially constructed foot-controlled dispenser 
illuminated by a fibre-optic supplying UV-light. 
Cyanoacrylates are already being used as tissue adhesives in place of the 
conventional but potentially disfiguring suture. The availability of 
improved, imperceptible adhesives and a precision applicator, which can be used in a modern operating theatre, will extend their effectiveness 
and satisfy some of the needs of Plastic, and Oral and Maxillo-Facial Surgeons. Portable applicators have potential use in battlefield and in 
veterinary surgery and overcome the imprecision characteristic of 
earlier methods. 
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INTRODUCTION 
Ever since man began to live in organized groups which marked 
the beginning of civilization the desire to be of acceptable appearance 
became as basic as the will to live. The face with its expressions of 
all human emotions is a vital means of communication and represents the 
centre point of attention in human relationships with particular emphasis 
placed on cosmetic acceptance. 
Many patients who have facial or body defects resulting from 
cancer surgery, trauma or congenital anomalies benefit from prosthetic 
rehabilitation. Plastic and reconstructive surgery has developed to 
the point where gross deformity, both congenital and acquired, can be 
corrected or improved by surgical means. 
The use of the patient's own tissues is far more desirable 
than employing synthetics. However reconstructive surgery produces 
satisfactory results only if the case is suitable. In many cases there 
is a period between the establishment of the deformity and the commence- 
ment of surgical procedures, and the provision of a temporary prosthesis 
is of considerable psychological as well as practical value. 
There are also cases which are considered inoperable due to 
the Possibility of recurring disease and general health of the patient. 
In such cases the provision of a permanent prosthetic reconstruction 
is essential. Patients who have suffered extensive burns to the face 
and body of a severity requiring skin cover often have insufficient 
tissue locally available for reconstructive procedures. 
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A feature of cancer surgery is the requirement to remove an 
A, 
extensive section of tissue adjacent to the tumour which can result in 
considerable post-operative deformity. The immediate result of this 
necessary surgery is that the patient has completely changed. facial 
features: what was once an acceptable and familar face to family and 
friends is different and often not readily accepted by society in general. 
Advances in materials science have illustrated that synthetic 
materials can be developed and applied to the human body in support of 
surgery. Attempts to substitute materials for defective or missing organs 
or parts have been made throughout the history of medicine but only in 
the last 20 years have techniques met with consistent success. 
Few materials qualify for clinical application to humans. The 
Polymer industry has developed many new materials, most of these for 
intended industrial applications. From time to time a particular polymer 
has been found to have some properties which might apply to clinical 
prosthetics or surgery but all too often the seemingly ideal material 
fails to meet the demanding specifications required. There is a definite 
need for a resilient polymer for prosthetic reconstruction and simulation 
of human tissue together with a reliable and effective means of attachment 
of the material to the body surface. 
ýý` 
The bonding of synthetic devices to the skin has constituted 
a major problem in prosthetic rehabilitation. The use of adhesives in 
medicine and surgery is an area of rapid development with important con- 
sequences to the future progress in surgical practice. 
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This study is concerned with the development of a structured 
silicone elastomer formulated for prosthetic reconstruction in plastic 
surgery, together with tissue adhesives. The prosthetic elastomer 
concerned in the study has been developed to meet the specification 
required of the ideal prosthetic tissue substitute and has found 
comprehensive clinical application in the department of Plastic and 
Maxillo-Facial Surgery at St. Luke's Hospital, Bradford. 
The development of adhesives in this study has complemented 
the prosthetic elastomer in the attachment of prostheses and devices 
to the skin together with the bonding of tissue and precision application 
of the adhesive as an alternative to conventional ligation. 
PART I FACIAL PROSTHETICS 
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HISTORICAL REVIEW 
The Royal Library Copenhagen records that a Danish astronomer 
Tycho Brahe (1546-1601) lost his nose in a duel over a woman's favours. 
He lost the dual, the woman and his nose. A resourceful gentleman he 
constructed a new prosthetic nose for himself from silver and gold. 
WHYPER (1832) recorded in the London Medical Gazette, the case of the 
Gunner with the silver mask -a complex mechanical facial restoration 
for a young French soldier with an extensive facial defect acquired in 
battle. Whyper describes the prosthesis as weighing some three pounds 
and costing £12 sterling. Skin colour simulation was by means of oil 
paint "analagous to his complexion so that the illusion was so strong 
that unless forewarned the man might be steadfastly examined at a short 
distance without betraying his misfortune. " 
TETAMORE (1899) used Celluloid painted to a flesh colour in ten 
cases of patients with nasal defects. UPHAM (1901) describes his work 
constructing noses and ears. He comments on the materials available for 
his work ... "Vulcanized rubber is the best material to use. It is more 
easily worked, has no odour and is not easily broken. I find Celluloid 
hard to work, it gets broken and has the misfortune to catch fire if the 
wearer is an absent-minded smoker! Aluminium and silver are too hard 
and do not keep the enamel flesh colour on the surface. " 
WOOD (1917) an artist and captain in the Royal Army Medical 
Corps attached to the 3rd London Military Hospital at Wandsworth 
records his construction of prostheses. His facial prostheses were 
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in the form of 'masks' cast in copper and silver plated, after which 
they were realistically painted in oil paints to reproduce as faith- 
fully as possible the former appearance of the patient. Wood devised 
these permanent prostheses to take the place of the soft vulcanised 
rubber and gelatin mixtures currently used at that time, which he 
describes as of "minimal success in the many cases of facial disfigure- 
ment sent to me from the battle front. My work begins where the work 
of the surgeon is completed. The surgeon does all he can to restore 
function by bone grafting and skin grafting. I then endeavour by means 
of the skill I possess as a sculptor to make a man's face as near as 
possible to what it was before he was wounded. " 
The use of facial prostheses through the ages illustrates 
man's ingenuity and application of materials to replace lost anatomical 
tissue. 
The origins and first use of prostheses to reconstruct facial 
and body defects are lost in antiquity. Some appreciation of man's 
earliest attempts have been seen from excavated remains, together with 
illustrative carvings, sculptures and paintings. The Chinese are 
known to have made facial restorations using waxes and tree resins. 
GRAY (1967) in a radiographic study of Ancient Egyptian 
mummies refutes the long standing hypothesis of BULBULIAN (1945) and Perp¢ 
rua( 
CHALIAN et al. (1972) that the ancient Egyptians used facial prostheses 
such as noses, ears, and eyes. Gray's study shows that the prostheses 
were used solely in a post-mortem role. 
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As early as the Fourth Dynasty (2613-2492 B. C. ) mummification 
was used with particular attention being paid to the face. Mud or 
sand was packed under the facial skin and linen placed in the mouth to 
restore contour. Artificial eyes were inserted into the orbits, made 
of materials such as limestone, calcite or bone (Fig. 1). 
Balls of linen were also used, the pupil represented by a spot of 
black paint. These eyes were considered an innovation from the Twenty- 
first Dynasty. 
This restoring procedure was further complementedby facial 
painting with ochre red for a man and yellow for a woman. The process 
of mummification was an expensive procedure mostly confined to the 
aristocracy. 
Ambrose Pare (1510-1590) can be described as the founding 
father of facial and body prosthetics. His construction of prostheses 
and, in particular, facial prosthetics did much to form the basis of 
future development in the field of reconstructive prosthetics (Fig. 2). 
The materials used by Pare were gold, silver, paper and linen enamelled 
to create the illusion of skin colour (PARE, 1579). 
Figure 1 Calcite artificial eyes. Fourth Dynasty (2613 - 2492 BC) 
used in mummification 
Figure 2 Ambrose Pare prostheses (1510-1590) 
10 
TIE SKIN 
Colour 
Many factors make up the quality of human skin described 
as 'life-like'. Colour is one of the main important factors in 
, patient acceptance in a facial prosthetic material. 
The object of workers in the field of prosthetic restoration 
has been to duplicate and simulate normal human skin so that the 
prosthetic restoration will appear realistic. 
The absolute covering material for the human body has yet to 
be defined, however for the task it has to do the skin is worthy of 
examination to form an understanding of the many problems of finding a 
prosthetic substitute. 
Human skin is resistant to wear. It replaces itself. It is 
warm in winter yet cool in summer. It has a resistance to damp, 
corrosive elements and micro-organisms and its aesthetic properties can 
much influence the social acceptance of its owner. HARRY (1962) gives 
the total area of skin covering a six foot 70 kg male as 1.9 m2 and the 
weight as approximately 2100 g. 
In its ideal state the skin appears perfectly smooth. How- 
ever, as skin ages, it is more exposed to heat and cold, pressure and 
abrasion. In order to reproduce skin colour to an acceptable degree 
in a prosthetic material it is necessary to examine briefly the structure 
of human skin with regard to pigmentation. 
11 
The aesthetic colour of a translucent surface like that 
of human skin results from the scattering of unabsorbed spectral 
el 
regions throughout the heterogenous surface and substrate layers with 
A 
highly diffuse reflectance by the internal dermal structure. Human 
skin comprises a series of translucent layers (Fig. 3), the outer 
epidermis, the dermis and the subcutaneous tissues, each containing 
various pigments contributing to the sensible colour of skin. When 
seen in light some of the incidental rays are reflected from the 
surface unchanged contributing to that quality of human skin termed 
gloss, often thought to be only shine. The remaining light enters 
the epidermis and is either absorbed, transmitted or reflected with 
diffuse scattering depending upon the spectral colour character- 
istics of the pigments in the dermal layers. The total reflection, 
both direct and diffuse, contributes to the visual stimulus with the 
process continued in the dermis and subcutaneous tissue layers. The 
overall visible sensible colouration of human skin is therefore a 
complexity of absorption, transmission and reflection, depending upon 
the location, depth and amount of colour particulate producing 
pigments and upon the diffuse nature of the skin layers. 
Previous workers in skin colour, SCHULTZE (1926) and 
WILLIAMS (1933) considered only specific pigments namely melanin and 
haemoglobin. No consideration was given to reduced haemoglobin and 
neither carotene nor melanoid was recognised as a normal constituent 
(EASTWOOD, 1978). The epidermis was considered a screening factor 
for underlying blood. Roberts, in the study of skin pigmentation, 
describes human skin colour as attributable to five prevailing pig- 
ments - Melanin, Melanoid, Haemoglobin, reduced Haemoglobin and carotene. 
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Figure 3 
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These pigments (Table 1) absorb specific spectral regions and reflect 
colour characteristics. Melanin, found principally in the epidermis, 
is the basic dark pigmentation and is responsible for the yellow and 
brown effects of the skin. McANDREW (1963) in an investigation of 
skin pigmentation, describes melanin as a coloured protein complex 
indicating "tinctorial" differences that are seen in the skin, hair 
and eyes of man. A microquantitive study of human dermis established 
that the variation in the hue of the skin in Caucasian, Negro and 
Mongolian (racial groups described as having white, brown-black and 
yellow skins respectively) is not related to the number or distribution 
of pigment producing cells which appear to be the same for all races, 
but to the content of melanocytes. The melanocyte beingthe pigment 
bearing cell which secretes melanin. SZARBO (1959) determined that 
the epidermis is on average 10 cells in depth,. the melanocytes being 
situated in the lowermost epidermal cell layer of the epidermis 
(Figs. 4& 5). 
Table 1 Principal Pigments in Living Tissue 
Pigments Location Qualitative Colour 
Melanin Basal layer Brown and yellow 
bluish tinge 
Melanoid (sol. ) Basal layer 
Oxyhemoglobin Capillary tips Red 
Hemoglobin Capillary tips Blue red 
Pink tone 
Carotene Tissues and Yellow and red 
stratum 
corneum 
' 1 
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Figure 4 Section showing normal epidermis of a negro. 
The upper black zone in the prickle cell layer 
is the normal granular layer, with granules 
composed of keratohyalin - not melanin. The 
basal laye L 
4hows 
intense pigmentation with caps 
composed of melanin granules above the nuclei. 
(H&EX250) 
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Figure 5 Section showing normal epidermis of a 
white Caucasian. The basal layer(') 
lacks the intense pigmentation seen in 
that of the negro. 
(H&EX250) 
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A horizontal pigmented network is formed by long cytoplasmic 
extensions of melanocytes interconnecting and weaving in among the 
other epidermal cells; within these melanocytes the amino acid 
tyrosine is enzymatically converted into melanin. BLUM (1959) describes 
the principal role of melanin in the human skin to be that of a light 
trap, an epidermal screen of pigment protection placed between ultra- 
violet light and the highly vascular dermis. 
EDWARDS and DUNTLEY (1939) are credited with the identification of 
a new pigment. On examination of the stratum corneum they found a 
pigment resembling melanin in its general pattern of absorption but 
differing in that the new pigment had an absorption pattern in the 
violet of the visible spectrum. Because of its resemblance to melanin 
they designated the pigment "Melanoid". Since melanoid resembles 
melanin spectrophotometrically and since it is found in cells derived 
frm the melanin-bearing cells, it is thought logical to regard melanoid 
as a degradation product of melanin: the amount of melanoid found in 
any skin is related to the amount of melanin found there. 
Skin colour difference between sexes 
It is generally accepted that women are of a lighter skin 
colour than men. This is not as might be expected attributable to 
environmental exposure and work patterns. STRONG (1927) found that 
the female skin contains less blood and melanin. He identified the 
strong melanin areas in the female skin as the nape of the neck and 
17 
the axilla. Carotene being distinctly more evident in the female 
than the male, mostly-in the breast and abdomen in contrast to the 
male who shows little carotene in these regions. 
Skin colour differences in the races 
The work of EDWARDS & DUNTLEY (1939) and FITZPATRICK (1961) 
confirms that the quantity of melanin is alone responsible for the 
colour difference in the dark skinned races. Edwards and Duntley 
further define the principle colour differences to extra melanin 
derivative melanoid. The research findings of skin colour indicate 
that coloured races owe their characteristic skin colour to variations 
in the amount of melanin. To this pigment must be added the derived 
pigment melanoid. No pigments other than those found in the white 
races are encountered in the dark skinned races and the general pattern 
of pigment distribution is identical in both groups. 
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I 
DEVELOPMENT 
Of the many difficulties encountered in facial reconstruction 
by prosthetic means, the material used is of particular importance. 
The colouring of the face and skin is not uniform and is subject to 
constant variations due to temperature, emotion and general health, 
all presenting individual problems. Few materials qualify for use as 
facial prostheses since the exacting specifications required for 
human tissue substitution are difficult and, in some respects, 
impossible to simulate in a synthetic material. Living tissue is 
constantly adapting and replenishing, being always in a dynamic 
state. 
Although a prosthetic material can never simulate these 
dynamic facters, many materials have found application throught the 
years. It was not until the later part of the 19th Century that 
the "plastic" materials were used. BULBULIAN (1945) used vulcanite 
rubber and cellulose nitrates. These early prostheses were rigid 
and heavy, colour being imparted to the outer surface, and failed to 
provide the lifelike appearance required. TUCKFIELD & WORNER (1945) 
found Poly(methyl-methacrylate) to have many advantages with regard 
to translucence and colour. They recognised that the material had 
potential despite being a rigid polymer. It is of interest to note 
that until 1960 some 95% of facial prostheses constructed in the 
United Kingdom were of Poly(methyl-methacrylate) (ROBERTS, 1968). 
The first noted departure from the concept of rigid materials has 
been credited to ZINSSER (1913), BERCOWITSCH (1928) and BATSON (1935). 
These workers used a flexible gelatin glycerine compound. However, 
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the functional life of this compound was limited to only a few days 
before hardening and discolouration occurred. BULBULIAN (1939) and 
CLARKE (1941) made extensive use of prevulcanized latex in liquid 
form, but again the duration of effective use by the patient was 
limited because of severe shrinkage and discolouration. Liquid 
prevulcanized latex found favour until the introduction of plasticizers 
for vinyl resins in the 1940s. HUME (1943), TYLMAN (1943), FONDER(1 955), 
FENN LIDDELOW and GIMSON (1961), ROBERTS (1966) used poly(vinyl chloride) 
for the construction of facial prosthetics. The physical properties 
following a period of wear were found to deteriorate together with 
loss of colour. This material was considered to have advantages 
over all others until the introduction of silicone elastomers to 
facial prosthetics. BARNHART (1960) introduced silicone elastomers. 
He used a room temperature vulcanizing (RTV) (Silastic) in combination 
with Poly(methyl methacrylate) dental stainer polymer. The dental 
polymer was used as a filler and intrinsic colour base. Some of 
the physical properties of the elastomer were unsatisfactory, in 
particular tensile strength and tear strength. The Poly(methyl 
methacrylate) polymer produced a granular effect on the elastomer 
resulting in low resistance to deformation (ROBERTS, 1971). 
A number of contributors to facial prosthetics have used 
modified silicone elastomers. MATALON et al. (1968) used a clear 
RTV elastomer pigmented by means of Du Pont oil soluble dyes. 
CHALIAN (1968) employed heat vulcanizing elastomer (Silastic MDX 
44514). He introduced metallic oxide pigments in the material by 
means of a small roller mill. AL-QUDSI (1968) used a silicone 
elastomer (Silastic 382), coloured with metallic oxide pigments. 
* RTV.. Room Temperature Vulcanizing 
ýw 
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KANTER (1970) reports the use of an RTV elastomer (Derma-Sil'). 
He coloured the translucent elastomer base by means of mineral pig- 
ments. ROBERTS (1971) described the use of a clear prosthetic 
elastomer base (Silastic 399). The skin colour of the base was 
simulated by art powder pigments. Extrinsic tinting was achieved 
by use of the pigments in a paintable solution of elastomer. The 
immediate aesthetic effect was satisfactory, but again the material 
had a short functional life and a low tear strength. SCHAAF (1970) 
used heat vulcanizing elastomer (Silastic MDX 44515) and a RTV 
elastomer (Silastic 399). Metallic oxide pigments were used to 
obtain intrinsic colours. The final colour characterization of the 
prosthesis was achieved with water colour pigments introduced into 
the vulcanized elastomer by means of a tattoo needle. PRATT (1973) 
described the use of colour batched RTV elastomer (Silastic 399) 
blending the colour batches to form a skin colour base elastomer. 
WELLINGTON & PAGE (1974) used Rhodorsil coloured by art oil pigments. 
Because the elastomer used was an industrial grade they bonded a 
polyethylene sheet to form a fitting surface to the skin. LONTZ 
et al. (1974) have combined an RTV silicone elastomer (Silastic 
372) and a high temprature heat vulcanizing elastomer (Silastic 
MDX 44515). They describe the combined elastomer compound as having 
a modulus of elasticity close to that of human tissue. The claim 
is based on data of 8 to 3.7 x 104 Nm-2 for the modulus of 
elasticity and a strength-to-modulus quotient of 17.5 as derived 
from stress-strain profiles of fresh canine artery. AINA et al. 
(1966) used an RTV elastomer to simulate negro skin colour. 
Pigmentation was by use of inorganic iron oxides. He concluded 
that silicones could be pigmented to reproduce negro skin colour 
and texture with good aesthetic properties. 
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Materials currently used 
Acrylic Resin 
Poly(methyl methacrylate), so common to dentistry as a denture 
base and tooth material, is readily available and inexpensive. A wide 
variance of skin tone colours can be achieved by means of high concentrate 
acrylic polymer stains. The simple technology involved of combining 
the monomer and polymer followed by conventional dental laboratory 
polymerization have kept the rigid material in use. ROBERTS (1966) 
describes the disadvantages of rigid polymers as: 
1. Discomfort at the site and surrounding areas of 
the defect. 
2. Lack of response to facial movement. 
3. Surface shine following a short period of wear. 
4. Limited use in undercut areas used for retention. 
5" Unsuitable for cosmetics. 
6. Psychologically less acceptable to the patient 
than flexible materials. 
If able to conform to the physical characteristics required, 
flexible materials have distinct advantages over rigid materials. 
They are: - 
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1. Comfort in contact with the tissues. 
2. More readily adaptable to the contour and periphery 
of the defect. 
3. Some facial movement reciprocated by the material. 
4. Undercut areas may be utilized for retention. 
5. Surface texture more readily takes cosmetics. 
6. More than one prosthesis can be constructed from 
the mould. 
Vinyl Resins 
A plastisol is a dispersion of the resin in a compatible 
plasticizer which, when heated to a prescribed temperature, can be 
converted from a viscous fluid to an elastomeric polymer. An organisol 
is an emulsion of the plastisol with volatile thinners. The thinners 
are usually aromatic and aliphatic hydrocarbons, or a blend of these. 
Numerous plasticizers have been used for compounding plastisols and 
organisols. These constitutents of the material often migrate from 
the cured material and as such have come under investigation with regard 
to toxicity (BOWERY & LEWIS, 1968; HOLLINGSWORTH, 1971; GILDING, 
1977). 
The final physical properties of the plastisols and organisols 
when cured depends on the molecular and particle size together with 
the formulation used in their production. The temperature of gelation 
is important. Some of this group of materials require a temperature 
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of 190°C to obtain the maximum physical properties, and need 
metal moulds to effect sufficient heat transfer. LAMMIE & STORER 
(1977) and CRAIG & GIBBONS (1963) describe the inherent character- 
istics in these materials as that of a plasticizer migration resulting 
in an initial loss of physical and mechanical properties. Facial 
prostheses constructed from plastisols and organosols discolour, 
harden, shrink and lose their flexibility. These physical and 
mechanical changes occur within 3 to 6 months representing an 
unacceptable wear period - for a prosthetic restoration. KING 
(1970) 
indicates that the material is unsuitable for use if the patient 
lives in a high temperature, bright sunlight environment. 
Pol uurethane Elastomers 
Polyurethanes are among recent polymers introduced to facial 
prosthetics. GONZALEZ (1970) has used polyurethane with success. 
FRICH (1969) describes polyurethane polymers as being characterized 
by the linkage or presence of urethane groups, although other groups 
such as esters and ethers may be present in the molecule. These 
elastomers are synthetic formulations of long chain linear polyesters 
or polyethers reacted with disocyanates. They can be thermoplastic 
or thermosetting. Gonzales describes the material as being, when 
correctly processed, chemically inert, resistant to solvents and ozone, 
and having a high tear strength. The modulus of elasticity of the 
material resembles that of soft tissue.. The disadvantage of the use 
of Polyurethanes is the degree of precision required in processing, 
and the complex equipment and instrumentation required. MARGETIS 
(1978) describes an experimental two component polymer facial prosthesis 
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material formulated from latex and Poly(methyl-methacrylate) cross- 
linked with formaldehyde. This material has organic pigments 
dispersed in the underside of the surface layer of the acrylate skin 
to achieve the illusion of depth. Final colouration is by use of an air 
brush to apply organic pigments in a vinyl solution. 
Silicone Elastomers 
Polysiloxane elastomers have found a prominent place in 
facial prosthetics. Medical grade polysiloxane elastomers now have 
a good history in surgery and medicine. The first attempts to find 
applications for silicones in the medical field were made by BARONDES 
& JUDGE (1950) and BROWN & FRYER (1953). This group of elastomers 
is relatively inert, flexible, biologically compatible, chemically 
resistant to ozone and indifferent to temperature changes. Their 
absorption of body fluids is low (LONTZ et al., 1974; ROBERTS, 
(1976). 
Silicone elastomers are available in two main vulcanizing 
groups - heat vulcanizing and room temperature vulcanizing. The heat 
vulcanizing elastomer may be modified by fillers to achieve a wide 
rubber 
range of International hardness degrees (IRHD). However, the most 
common is that of IRHD 30-50-70, grade 30 having found most applic- 
ation (DRANE, 1970; FRISCH, 1978; GUIGNOT, 1978). The vulcanizing 
agent used in elastomers for prosthetic application is dichlorobenzoyl 
peroxide. The temperature required to complete vulcanization is around 
150°C followed by a post-vulcanization cure. Colour can be introduced 
prior to vulcanization by means of a roller mill. WINTER (1983) 
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described the formulation of a room temperature curing elastomer 
for facial prosthetics (Cosmesil). The base elastomer is in 
transparent form, and by the addition of curing additives, a cross- 
linking agent and catalyst, a high tear strength soft tissue-like 
elastomer can be produced. Colouring agents suspended in silicone 
fluid provide a colour range to simulate basic skin shades. The 
final cured prosthesis can be tinted by extrinsic pigments. 
The room temperature vulcanizing silicone elastomer can be 
seen to have been extensively used for facial prostheses. The elastomers 
are available in one and two component systems, and require mixing 
and colouration. The two component system is the most common RTV 
elastomer used in facial prosthetics. The components are catalyst and 
the base compound, silicone polymer containing filler. Because of the 
need to mix in a catalyst and colourants, the viscosity of the polymer 
used is low. The catalyst used is stannous octoate. In the one 
component system, the polymer base already contains the formulation 
for vulcanization which takes place in contact with water vapour in 
the atmosphere. Chemical condensation takes place resulting in 
continuous displacement of the equilibrium by the evaporation of the 
acetic acid formed. Vulcanization begins at the surface and proceeds 
towards the interior as water diffuses in and acetic acid diffuses 
out. This single component system has not found general accept- 
ance for facial prostheses. HULTERSTROM (1976) found application 
for this elastomer in ear prostheses, colouring the elastomer with 
organic pigments. The mechanical properties of this elastomer are 
not sufficient to withstand the daily usage by facial prosthesis 
patients. Its main application is that of an adhesive and can be 
26 
used to complement and repair silicione elastomer restorations and 
as a sealer for extrinsic tinting. The problem of room temperature 
vulcanizing elastomers applied to facial prostheses has been the 
poor mechanical properties and difficulty of colour simulation. 
Most RTV prostheses can be described as fragile with poor tensile 
and tear strength. These limitations have received attention during 
this research. 
The development of materials for prosthetic facial recon- 
stitution has been equal to the advances made in materials science. 
Complimentary to this has been the understanding of the structure and 
physiological function of human skin. The most satisfactory materials 
which can be formulated to simulate skin and tissue are polysiloxanes. 
The research thrust at this centre has been to develop a 
silicone elastomer for use in prosthetic reconstruction in support 
of plastic and maxillo-facial surgery. 
Retention of Silicone Elastomer Facial Prosthesis 
The development of silicone elastomers for facial prostheses 
has extended the range of methods of retention to take advantage of' 
the physical properties of the material. 
The success of a prosthetic restoration depends on the means 
and method of retaining the prosthetic material in the required location 
on the face. Confidence of the patient in the prosthetic reconstruction 
is enhanced by good retention. 
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The knowledge that the prosthesis will remain securely 
in position throughout daily routine further increases patient 
acceptance of facial reconstruction by prosthetic means. 
Perhaps the most significant advance in the retention of facial 
prostheses in this category is that afforded by the implantation of 
osseointegrated fixtures. This method of retention termed "osseo- 
integrated retention" was introduced to the dental profession in 
1982 and has had a profound effect on the capacity of the oral surgeon 
to achieve a previously unobtainable level of oral rehabilitation. 
This technique has been of particular benefit to patients 
who suffer from insufficient retention preventing them from wearing 
conventional dentures. Osseointegration techniques in the oral cavity 
range from the partial endentulous to the entire dental arch. 
BRANEMARK et al. (1977) first described his new dental implant system, 
the osseointegrated screw. ALBREKTSSON et al. (1986) reported z 
ten year clinical success rate of more than 90 per cent. The positive 
outcome of this osseointegrated screw technique is attributed to 
a firm implant bone anchorage without interposed soft tissue and a 
reaction-free mucosal penetration (BRANEMARK et al. 1985). 
In 1985 Branemark reasoned that it ought to be possible to 
use a skin-penetrating implant on the same principles as the osseo- 
integrated dental implant representing the device that permanently 
penetrates the soft tissue of the oral cavity. 
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From this concept the clinical program of percutaneous 
titanium implants commenced (TJELLSTROM et al. 1981). ALBREKTSSON et al. 
(1987) gives two indications for this surgery: 
1. A stable anchorage of an external bone-anchored 
aid in certain cases of hearing disorders. 
2. A stable anchorage of a facial prosthesis. 
ALBREKTSSON reportedthe use of 389 skin-penetrating implants 
used in one of these indications in 174 patients. 
The skin-penetrating abutment implant 
The implant is in the form of a 3.75 mm wide 3- or 4 mm 
long screw of pure titanium (99.75 per cent pure with 0.05 per 
cent iron, 0.10 per cent oxygen, 0.03 per cent hydrogen) ALBREKTSSON 
et al. (1983). The implant has a flange to prevent accidental 
perfor ation of dural structures during surgery (Figs 6& 7). 
A 
Brief outline of surgical procedures 
A curved skin incision is made under local anaesthesia and 
a periosteal flap dissected and raised. The bone is drilled at a 
very low rpm with profuse saline cooling. Enlargement of the drilled 
hole is gradualby means of larger drill bits. 
The hole is threaded with a tap of pure Titanium at speeds 
of some 20 rpm. A main point at this stage of the surgery is to 
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Figure 6 Skin-penetrating abutment 
Figure 7 Sectioned abutment assembled 
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prevent trauma and damage to the bone. 
Into the threaded hole a titanium fixture is placed 
using rotary instruments. To protect the top of the inserted. 
implant and the internal thread a cover plate screw is placed. 
Finally the skin flap is replaced and closed. After a period of 
some three to four months the implant fixtures become fully 
integrated in the bone. 
At the second stage of surgery a new skin incision is 
made around the implant site and subcutaneous tissue removed to 
achieve tight contact between skin and underlying bone. The cover 
screw of the integrated implant is replaced with the titanium 
abutment (Figs. 8& 9) which penetrates the skin. Some four weeks 
later it is possible to start the construction of the superstructure - 
prosthesis. The bone anchored (osseointegrated) implants are 
connected by means of a lost wax cast 18 ct. gold superstructure (Figs. 
10 & 11) and on this connecting superstructure the facial 
prosthesis is incorporated (Fig. 12). The facial prosthesis is 
then able to be clipped into position. 
There are many potential indications for permanent skin- 
penetrating implants to retain prostheses and devices to the body. 
Facial prostheses constructed to percutaneous osseointegrated 
implants have advantages apart from firm fixation, these are, 
defined alignment and margin integrity. 
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Figure 8 Titanium abutments connected to integrated implants 
in orbital margin for prosthesis location and 
retention 
Figure 9 Prosthetic Silicone Elastomer orbital restoration 
with superstructure incorporated 
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Magnets 
A method of facial prostheses retention by magnets is 
described by SWARTZ et al. (1982) (Fig. 13). Samarium-Cobalt magnets 
were implanted into subcutaneous pockets in three patients. This 
technique was used to achieve instantaneous fixation and orientation 
of the facial prosthesis. Sm-Co magnets are produced by compression 
of the elements of samarium and cobalt, both of which are initially in 
powder form. 
The two elements are fused under conditions of'high temper- 
ature and pressure. High magnetic fields are maintained as the powders 
are compressed into solid metal blocks. TSUTSUI et al. (1979) used 
Sm-Co magnets as a dental material and established the high corrosion 
resistance and inertness of the Sm-Co magnets. 
SWARTZ et al. encapsulated the magnets used in their study 
with methacrylate to increase the inertness of the implant. 
The Sm-Co magnets exert a 50 per cent increase in magnetic 
strength over conventional chromiumsteel magnets. Following implant- 
ation of the magnets the facial prosthesis with mated Sm-Co magnets 
was constructed. Swartz et al. report good retention and orientation 
in the three patients described. The use of implanted magnets has 
been further extended for experimental fixation of devices to the 
body, and could be a method of retention for long term attachment 
in ileostomy patients (SANDEI et al. 1979; HOLLENDER et al. 
1976). The disadvantage of percutaneous implant methods of retention 
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is that surgical procedures are required. Post operative 
infection 
and discomfort are also considerations. The high cost of the 
implants 
and instrumentation involved are further restrictions to this 
form of 
retention. Patients who would benefit from retention by implants 
require careful selection and post operative management. The alter- 
native and most frequently used method of retention is by contact adhesive. 
The use and development of adhesives to retain prosthetic devices is 
described in Part Three of this research. 
Evaluating Facial Prosthetic Materials 
The principal requirements for a successful facial prosthesis 
have been described by RAHN & BOUCHER (1970), and BULBULIAN (1967). 
A suitable material should be compatible with the supporting tissues 
and be non-irritant, have good elongation, tensile strength and have 
a similar modulus of elasticity to that of tissue. The material must 
not harden, and must retain its flexibility in a temperature range of 
5°C to 60°C. It should be capable of having its mechanical properties 
modified and controlled to the needs of specific prostheses. It must 
have a colour simulation of the skin on which it is placed and be 
reproducible. It must have a surface texture which is skin-like, be 
odourless, non-flammable and a poor conductor of heat. It must be 
dimensionally stable in its final form and thereafter be easily tinted 
and repaired. It must be easy to clean and resistant to abrasion, 
weathering body stainants and micro-organisms in the facial region. 
It must be relatively inexpensive, readily available commercially and 
be capable of laboratory manipulation. 
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The essentials of the ultimate criteria described may be at 
present beyond the current perimeters of our technology. At the first 
International Symposium on Facial Prosthetics, in the presidential 
address BEZROUKOV (1976) stressed the need for more evaluation of facial 
prosthetic materials, stating that there was little published evidence 
to indicate that clinical success could be correlated with measurable 
properties of facial prosthetic materials. 
In a review of the limited literature available the paramount 
difficulty is seen to be objective measurement and formulation of the 
significant properties of facial prosthetic materials. Two principal 
areas have lacked investigation. These are colour matching (aesthetics) 
and mechanical properties specific to patient acceptance. Following 
the pioneer work of EDWARDS & DUNTLEY (1939), CANTER (1978) considered 
colour to be one of the most elusive qualities to reproduce. He 
posed the hypothesis that a facial prosthetic material could be struc- 
tured to maximize a prosthetic material, in particular Silicone 
elastomer, to facial prosthetics. ROBERTS (1979) investigated the 
colour factor in Silicone elastomer used for facial prosthetics by 
means of reflectance spectrophotometry. In that study he measured 
the reflectance, of selected Silicone elastomers together with that 
of human skin. Different ethnic groups with differing melanin 
concentrations were'evaluated. Roberts, in his study, considered 
that since pigmented materials have colour because of a limited 
absorption of light at some point or points in the visible spectrum, 
examination of spectrophotometric curves would make it possible to 
identify the pigments required to match and colour simulate human 
skin in an ethnic group. He demonstrated that such a method could 
be used to achieve standard basic skin shades. 
_1 
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The shade formula used to pigment the prosthetic elastomer 
used in this research is the result of that study. The ROBERTS shade 
formula is based on a standard, observer system. The colour spectrum 
covers the maximum shade variation. Twenty-one shades are used 
(Table 2). This includes a blank base prosthetic elastomer. 
The formulation uses a high concentration of organic pigment, 
which conforms to EEC directives regarding purity of cosmetic and 
food colouring. Only micro amounts of pigment are required to effect 
appreciable shade change. 
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A brief Introduction to Silicone Polymers 
The synthetic silicone polymer can be defined as an alternating 
silicone-oxygen backbone chain with organic side groups, described by 
the following repeat unit: 
R 
Si- 0 where R is an organic radical 
R 
n 
By the variation of both "R" and "n" the polyorganosiloxanes 
are not a single product, but a group of highly diverse materials which 
can vary from thin fluids, to resinous products, and finally solid and 
elastomeric materials. 
Because of the inorganic backbone to the chain, the polymers 
have received much attention for both high and low thermal applications. 
In fact the first silicone materials manufactured commercially were 
silicone fluids in the form of grease-like materials used as insulation 
on spark plugs of military aircraft FORDHAM (1966). Today the use 
of silicones is diverse, and applied over a vast market range including: 
aerospace, aircraft, consumer, electrical, automotive and medical. 
Their use in medical applications has been a major success since medical 
grade silicone elastomers are: 
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1) Physiologically and chemicall inert. 
2) Not physically modified by tissue fluids. 
3) May be well pigmented towards skin tones with a 
similar texture and hardness approaching natural 
tissue. 
4) Ease of cleaning. 
5) Hydrophobic in nature. 
Chemistry of Formation of the Silicone Polymer 
The initial stage of the formation of the polymer in its simplest 
form, i. e. the dimethylsiloxane repeat unit, involves the reduction of 
silica to elemental silicon: 
Si02 +C- Si + CO2 
Under certain conditions, silicon undergoes a reaction with methyl 
chloride to produce dimethyl dichlorosilane as follows: 
CH3 
Si + 2CH3C1 - Cl -Si-ci 
CH3 
This product is vigorously distilled to remove the presence 
of any trifunctionality which would lead to undesirable branching in 
the polymer. The silane is now hydrolysed, 
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CH 
3 
C1-Si-C1 
CH3 
+ 2HOH - 
CH 3 
OH-Si--OH 
CH3 
"diol" 
+ 2HC1 
The diol is very unstable and condenses with a neighbour to 
form the silicone polymer plus water. 
CH3 CH3 
CH -Si-O H+ OH Si-0E - H2O 
CH3 CH3 
CH3 CH 3 
CH3 
+- Si--O i--O Si -0 
I-- 
CH3 CH3 
n 
The mechanisms for this reaction are very much more complex than the 
overall stoichiometric equation, for example there are about ten 
individual reactions to produce only the dimer (MARK & GAYLORD, 1977). 
The polymer chains are believed to be terminated by OH groups. 
With the addition of hexamethyldisiloxane, 
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CH3 CH3 
CH3 - Si -0- Si - CH3 
CH3 CH3 
the polymers can be end-blocked by methyl groups and the mixture 
equilibrated. 
CH3 CH3 
CH3 Si- .............. 
Si CH3 
CH3 CH3 
End of Polymer Chain. 
Predetermined average molecular wei¢hts may be obtained. 
The polymers are clear water-white fluids, with a viscosity depending 
on the mean average length of the polymer chain. The following table 
describes the molecular weight variance by both number average and weight 
average, with respect to viscosity measured in centistokes, thus an 
indication of the number of dimethylsiloxane units per chain length 
is given. 
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Viscosity of Pol dimeth 1 Siloxane Compared to Average Length 
of the Polymer Chain 
Approximate Number of Dimethyl Siloxy Units 
Viscosity By Number Average By Weight Average 
(Centistokes) Molecular Weight Molecular Weight 
0.65 2 2 
1.00 3 3 
2 5 5 
10 16 17 
50 46 60 
100 70 100 
350 130 200 
1,000 200 350 
10,000,000 3,000 5,400 
Silicone Elastomer 
There are basically two types of silicone elastomer, those 
which cure under the influence of heat, i. e. Heat Vulcanizing Silicones 
(H. V. ) 
and those which require no exotherm reaction to cure, i. e. Room-Temperature 
Vulcanizing Silicones (R. T. V. ). both contain fillers to increase their 
mechanical strength, and vulcanizing agents for cross-linking. However, 
they do not contain the wide variety of additives found in the majority 
of organic rubber compounds. Medical grade silicones contain no further 
additives except those mentioned above. 
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Curing Mechanism of Heat Vulcanizing Silicones 
The most commonly used filler within these silicones is a 
very finely divided silica with a particle size of approximately 30 mi. 
The percentage of filler is varied depending on the desired texture 
of the final silicone. Generally an increase in the percentage of 
filler to polymer increases the "hardness" of the final elastomer. 
There are two types of polymer available in this category, 
depending on the desired texture of the final prosthesis. 
Medium to hard grades are composed mainly of dimethylsiloxane 
units but with very small amounts of methylvinyl siloxy units copolymer- 
ised with it. 
CH3 
Si 
c 
il 
2 
0 
H 
Methylvinyl Siloxy Unit 
The above unit directly assists in the vulcanization of the 
polymer. 
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A softer grade of elastomer can be obtained by incorporating 
along with the above two units, a small percentage of methylphenyl 
siloxy units. 
CH3 
Si 0 
O 
Methylphenyl Siloxy Unit 
The addition of this relatively bulky phenyl group in the 
polymer chain is to reduce intermolecular forces, thereby reducing 
chain stiffness. The polymer is described as phenylmethyl/vinylmethyl/ 
dimethyl silicone copolymer. 
In order for vulcanization to occur the addition of bis-2,4- 
dichlorobenzoyl peroxide is essential. A small percentage (1%) of 
this vulcanizing agent is evenly dispersed into the silicone gum and 
with the application of heat the peroxide decomposes at relatively low 
temperature, such that cross-linking then occurs. 
The mechanism for this vulcanization is as follows: 
firstly the decomposition of dichlorobenzpyl peroxide to yield free 
radicals, followed by the free radical attaching itself to the vinyl 
group of the methylvinyl siloxy unit. 
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A new radical has been formed which readily subtracts a 
hydrogen atom from the methyl group of a neighbouring chain, at the 
same time the dichlorobenzoyl group detaches itself from the vinyl 
group. There are now two free radicals which can react to form a propyl 
cross-link. 
The dichlorophenyl radical is regenerated for further cross- 
linking. On completion of the network, the free radical decomposes 
and is not incorporated within the elastomev unlike sulphur chains in 
organic rubbers. 
The elastomer is basically a cross-linked silicone polymer with 
the addition of silica filler. 
Curing Mechanism of Room-Temperature Vulcanizing Siliciones 
There are two main categories of RTVs: two components and 
one component systems. The two component systems require a catalyst 
addition and polyfunctional cross-linking agents dispersed in the 
compound before vulcanization will occur, whilst the one component 
system requires only the presence of moisture. 
Two Component RTV 
The viscosity of these polymers are appreciably lower than 
that of HV elastomers, since the addition of a catalyst is necessary 
prior to use, which requires an even dispersion throughout the base. 
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For this reason the filler content is considerably less, and consists 
usually of diatomaceous earths, also the polymer chain is approximately 
seven times smaller in magnitude ('1000 silicone units) than that 
of HV elastomers ( 7000 silicone units). Because of these factors the 
RTVs are generally mechanically weak in comparison to HVs. 
Sn 
CH 
0 CH,, 
H 
H2--CH2-CH3 
2 
The mechanism for cross-linking is quite different to that 
of HV elastomers. The polymer used contains a high degree of hydroxyl- 
terminated polydimethyl siloxanes. 
C: c3 
HO 0- OH 
.111 CH3 CH3 CH3 n 
However cross-linking can only be accomplished with the use of 
polyfunctional cross-linking agents, for example esters of orthosilicic 
or polysilicic acids; such as the ester propyl orthosilicate 
Si (OCH2-CH2-CH3) 
4 
The resultant condensation reaction between silonol and propyl- 
oxysilane groups leads to cross-linking, with the elimination of alcohol. 
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MATERIALS AND METHODS 
A sample of currently available silicones used to construct 
facial 
protheses were considered in this research. These materials were 
mechanically tested in an attempt to relate the physical properties to 
their chemical composition, and to assess their suitability for use as 
soft facial prosthetics. Table 3 outlines the materials used and their 
respective supplier. 
No technical data was available from suppliers on the nature 
and percentage of fillers, the catalyst used for cross-linking purposes 
or the mean chain length of the polymer within the investigated silicone 
elastomers due to formulation confidentiality. 
Vulcanization of the HV Silicone 
The first three of these silicones namely "Polyshield", 
Mollomed and "HV 25" required no additional catalyst (the catalyst was 
present within the formulation). Both AB132025 and "Silskin" pastes 
required the further addition of a cross-linking agent, consequently 
they were of a much reduced viscosity in order to obtain homogenous 
mixing of the catalyst prior to use. A ratio of 10: 1, of polymer to 
catalyst was adopted for these two silicone elastomers. 
In all cases a pre-determined amount("-10 gms) of the gum/ 
paste, containing polymer, filler, and cross-linking agent was evenly 
dispersed into a mould. The she and, dimensions of this mould are 
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described in Fig. 14. Four "G" clamps were fastened to hand 
tight pressure at each corner of the plates to clamp the mould. 
Vulcanization of the silicone elastomer was completed either 
by: 
(a) immersion of the mould into a water-bath 
at 100°C for one hour, 
or 
(b) Within a hot-air fan oven set at 150°C for 
one hour. 
After the vulcanization time interval the mould was removed 
from the heat source and allowed to cool to room temperature. The 
specimens were then removed and excess flash trimmed from the cured 
samples, which were already of a required shape for load-extension 
testing. 
Vulcanization of the RTV Silicone 
The previously described procedures for the HV silicones 
were adopted for the RTV silicones. "Silskin" is a two way elastomer 
in that it can be vulcanized either at room-temprature or at elevated 
temperature. At room-temperature, twenty-four hours under pressure 
is required to fully vulcanize the silicone, a temperature of 1500C 
for 1 hour in an oven or water-bath completes the high temperature 
vulcanisation. 
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"Silastic 382" required considerably less catalyst and vulcan- 
isation is rapid. The table below gives the catalyst concentration 
to working, and vulcanization times for this elastomer. 
Catalyst Concentration Ratio to Working Time for Silastic 382 
by Weight Working Time Vulcanization Time 
of Catalyst (approx. ) Mins. (Approx. ) Mins. 
1.0 4 mans 10 mins 
0.5 10 mins 30 mins 
0.25 30 mins 90 mins 
0.125 100 mins 180 mins 
Variation of the Ratio of Polymer to Catalyst 
For the heat vulcanizing silicione "AB132025" a 12: 1,10: 1, 
8: 1 and 6: 1 ratio of polymer to catalyst was used, and the mechanical - 
properties of the resultant vulcanized elastomers compared, to determine 
significant variations. 
The addition and Dilution of a Silica Filler to Medical Grade 
Silastic 382 (RTV) Silicone 
The main reason for incorporating fine particle fillers into 
these silicones is to drastically increase their mechanical performance. 
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For this reason an addition of silica filler known as "Aerosil"* 
(particle size = 16 mu) has been added to "Silastic 382" silicone 
elastomer and the mechanical properties compared. The filler content 
was also reduced by several dilutions of Silastic 382 polymer with 
silicone fluid; * again mechanical testing data have been compared 
with the original silicione elastomer. 
Mechanical Testing 
The mechanical testing in this research was completed on 
an Instron 1026 table top model tensometer. The mean cross-sectional area of 
each specimen was initially monitored with the aid of a micrometer 
gauge, prior to installation of the specimen within the specimen 
grips of the tensometer. 
The tensometer was initially calibrated using a5 Kg. weight. A 
constant extension rate of 50 mm/min. was maintained on the cross-head 
drive, with the same speed setting on the automatic chart recorder, 
thus extension on the chart recorder was the true extension of the 
specimen. The initial gauge length was monitored and kept constant 
throughout the testing. Load-extension charts were automatically 
plotted with the use of an autographic pen recorder. 
In order to determine the tear strength of these elastomers 
*Degussa AG, Frankfurt, W. Germany. 
**Medical fluid 360 20 cs viscosity, Dow Corning 
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a modified method to that outlined by the British Standards 
Institution BSI: (1982) was considered. This method was based 
on the use of a trouser test piece, and is preferred to the other 
techniques, since it is not sensitive to the length of cut made. 
Figs. 15 and 16 show the dimensions of the trouser test piece 
and the positioning of it within the testing machine grips. This 
is a modified version because the specimens are of different 
dimensions to that outlined in the standard. The last 1 mm of the 
cut forming the trouser shape was made with a scalpel blade. 
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Figure 15 
25.6mm_ 
00 
75 
Fisu , 
1-8: t 0-2mm 
>5. omm 
Trouser Test Piece 
Positioning of 
Trouser Test Piece in 
Testing Machine 
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RESULTS AND DISCUSSION 
Physical. Appearance of the Elastomers after Vulcanization 
On removal from the mould the vulcanized silicone elastomer 
had the general physical characteristics of organic rubbers well above 
their glass-transition temperature, since they possessed the ability 
to stretch and retract rapidly and were extremely flexible. No 
evidence of contraction in both HV and RTV specimens following cross- 
linking was observed. 
Mechanical Testing Results 
The stress-strain relationships for the elastomers were 
notably linear up to failure. This is of interest since the majority 
of organic elastomers are as illustrated in Fig. 17 in which there is 
a marked change in modulus (Y3 of original) after extension (usually 
200-300%). Fig. 18 describes a typical result using the HV elastomer 
(HV 25) recorded by the pen recorder during testing. An explanation 
for this linearity may be due to the relatively high percentage of 
filler incorporated in the elastomer, since pure silica would give 
a perfectly linear relationship of stress-strain up to failure 
(perfectly elastic behaviour) whilst gum with no fillers should 
behave as shown in Fig. 17. 
By combining the two graphs the marked change in modulus 
would become less significant for an increase in percentage of filler. 
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The following mechanical properties were determined from 
load-extension relationships. 
Maximum Tensile Strength 
where X and Y are integers. 
Load at Point of Failure 
Original Cross Sectional Area 
-2 
= XKg Fmm 
Xx9.807Nmm2 
Y MPa 
1 Kg F/m2 = 9.807 N/m2 9.807 x 106 N/mm2 = 9.807 MPa 
Maximum Percentage Elongation = Extension 
Original Gauge Length 
X 100 
= A% 
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Modulus (Rigidity) according to Hooke's Law 
Load 
E- Stress = Original Cross-Sectional Area 
Strain 
Extension of Gauge Length 
Original Gauge Length 
B MPa 
Tear Strength = 
Maximum Load Recorded Prior to Failure 
Mean Thickness of a Specimen 
=F 
d 
C KNm-l 
where F= maximum force in Newtons 
d= mean thickness in millimetres of the test piece 
where A, B and C are integers. 
Tables 4,. 5 and 6 show the results of mechanical testing. 
Results of the Variation of the Ratio of Polymer to Catalyst 
Table 7 describes the effect of varying the ratio of catalyst 
to Polymer. Both an increase and a decrease of catalyst led to a 
reduction in modulus, which has been well illustrated in Plot 1. 
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Table 6 
TEAR STRENGTH DATA FOR THE SILICONE PROSTHETIC ELASTOMERS USING TROUSER TEST PIECES 
Specimen Silicone Vulcanizing Mean Maximum Trouser Tear Mean Standard 
No. Compound 
Used 
Technique Specimen 
Th k 
force IF) Strength Tear 
h S 
Deviation 
m the f 
Room Water Oven 
ic ness Recorded 
IN) T,. f (kNm 
1) trengt 
kNm-1 
ro 
mean 
Temp Bath (1500C) d (mm) 
I HV 25 x 1.63 am 4.51 N 2.77 kNm 
1 
2 
x 1.60 " 4.36 " 2.73 1 2.68 kN ("0.08) 
3 x 1.51 " 3.87 " 2.56 " 
4 x 1.72 " 4.54 " 2.64 
5 1.62 " 4.49 " 2.77 " 
6 x 1.69 " 4.71 - 2.79 
2.97 " (. 0.19) 
7 
x 1.81 " 5.72 " 3.16 " 
- 
a x 1.96 " 6.22 " 3.17 
9 POLYSHSELD x 2.05 " 7.94 " 3.87 " 
10 " x 1.76 6.34 " 3.60 " 
11 3.61 (. 0.16) x 1.83 " 6.51 3.56 
12 
x 1.80 " 6.13 " 3.41 " 
13 
x 1.83 " 6.77 3.70 
14 
x 2.05 " 8.19 4.00 " 
15 3.92 " (. 0.19) 
x 1.83 6.91 3.7 8" 
16 
  1.96 6.22 " 4.19 " 
17 MOLLPOLAST-B x 1.70 0.96 " 0.56 " 
0.57 " (. 0.01) 18 " x 1.68 0.98 " 0.58 " 
19 `ý x 1.66 0.98 " 0.59 " 
20 0.60 " (_0.005 
1.53 " 0.97 " 0.60 " 111 
21 A8122025 x 1.35 1.81 " 1.34 " 1. aS (. 0.11) 22 
x 1.26 1.96 " 1.56 " 
23 
x 1.56 " 2.54 " 1.63 " 1.43 (. 0.21) 
24 
x 1.42 " 1.73 " 1.22 " 
25 SIEBKIN x 2.18 3.82 3.24 3.50 ! _0.26) 
26 " 
} 
x 1.41 " 5.30 " ) 3.76 " 
2' 
x 1.37 5.98 " 4.15 "l 3.91 " (30.261 
29 
x 1.15 4.21 " 3.67 
SILASTIC 382 x 1.38 0.72 0.53 
F 
x 1.52 " 0.98 " 0.65 O. SS i. p. tý7) 
x 1.57 " 0.88 0.56 ' 
32 
x 3.49 0.69 0.46 
64 
rl% 
4) 
cd H 
N 
N 
C9 
Z 
y' O 
aÖ 
w 
92 
s 
u 
ö 
., v 
y 
ö ro cý+f O 
c 
p be ýR t 2 ae 3R w 
N r n N O to t0 
j ý C j < 
C, 0 
N 
(D cNý 
40 
y C N .ý . -ý N N N N 
N N 
N N N N C\l N N N 
E 
N A ^ 
ý 5 2 2 
01 
XC4 
CL - 
N 
ßt1 
cl 
0 
CO 
Cl 
.+ 
r 
+ 
ý 
O ýp O 
Ul1 M U1 n 01 N UI M ýp 
0 
F. 
N 
.+ O O .+ 
. 
.r .. 4 ., 
O 
.r 
OD 
O 
n 
.+ 
O 
.r 
O 
.r 
O 
.r 
(f 
.ý 
N 
.r 
O 
.. 
EU, 
- en Ul 
ý' 0 
IA N to p Q Q Q cy t'') r f tom) C UI Q 
3 O O O O O 0 0 0 0 0 
1 
0 0 O 0 0 0 
O 
E C 
. ý; ^ 
- 
^ (0 
to 
C) 
N ä 
ýQ 
ö ö .. ". is to O ; ; C 0 r N O O 
to N N N - N N N ö 
N 
45 
4 
m S 2 - 2 L S S - . _ - _ 
y 4ä co V N t0 
N 
ßf1 
N 
t00 
~Q 
Y 
In O Q O 
. 
° ý co t0 elf M OD Of W 0 ý[1 
( ) 
r m 
ýp 
py .r O 0 ' ö ö ö 0 ö ö ö ö ö c ö ö o - .: 
ý 
o 
^+ L E E S i S L S 
s1U N U 
n Go 0 n N co 0 i 400 co 0 co t 0 
2 
N 
10 
.r 
45 
US*4 UH 
ö "E - - 
2 - 2 - 2 - s _ S i s vä - - 
v a ( ' N i to "- a 
ÜO 6 L L L S 2 2 S L i 2 S - - ö 
CN to . L t 
t7 
0 
ýp 
O 
N) 
p 
t0 
n 
aý 
41 
: 
N 
co 
e9 
p 
Cl 
co 
n p n Cl tyý p C 0 jy . 
T fa. N<;. 
ý M 
N 
tý1 
-4 
l7 
.. 1 
N 
N 
N 
+1 
.ý 
H 
N 
N 
.ý 
H 
n 
.r 
H 
.+ 
.+ 
N 
IA 
.r 
N 
co 
.y 
rl 
4D 
.r 
A 
N 
.. ý 
wM 
U) 
N 
'I 
V 
N 
M 
oC) 
> k x X k tt X k k k k k k k k x X V 
CC 
v c N C)r e -W Ai 
vý im Ur 
>F Ö N 
CF 
0 ý 
L. N 
E ma 
i r - .r 
41 Q 
- N 
, .0 
C 
UO 
vz 0 - N (+) p UI 40 r (0 Cl 0 .+ N c., ' 0 (0 A -4 N ti H H ti 
65 
Z 
Z 
O 
to 
a 
U 
Q 
W 
La- 
W 
º-- 
z 
s 
V 
W 
LA- 
aö 
'! 7 
CK31 
r- ö 
N 
0 
>- 
Q U 
Q 
W 
ZE 
/-- 
C* 
4-- NO smnoorr 
Plot 1 
ý "r N ýýÖ 
66 
Results of the Addition and Dilution of a Silica Filler to Medical 
Grade Silastic 382 (RTV) 
The incorporation of only a small percentage ( 4%) by weight 
of "Aerosil" silica filler was difficult to achieve a homogenous mix- 
ture due to the tremendous increase in viscosity. There was, however, 
a significant increase in both modulus and tensile strength (Table 8). 
Similarly a reduction of mechanical properties was observed by an 
apparent dilution of the filler. 
The results were found to be in agreement with mechanical 
performance data, since the elastomers with improved mechanical 
properties contained higher percentages of filler than compared to 
those with lower percentages. 
This investigation has critically assessed several available 
silicone elastomers used for facial prosthetics, and the following 
conclusions have been made. 
There was some variation in the mechanical properties for 
the elastomer "HV 25" between water-bath and oven vulcanization 
processes. The discrepancy is more obvious for the rest of the elasto- 
mers and is illustrated by the histograms in Figs. 19a, 19b 
and Fig. 20 which show mean mechanical property data and standard 
deviations from the mean versus vulcanization techniques. 
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In the majority of cases, oven vulcanization produced 
higher values for the mechanical properties. However, the variation 
was quite minimal and may be even less significant for larger numbers 
of test pieces. This slight difference may be due to incomplete 
vulcanization using a water-bath (100°C). McGREGOR (1954) indicated that 
"peroxide" vulcanizing agents decompose at temperatures above 115°C 
and preferentially at 150°C, and at lower temperatures the reaction may 
be too slow for practical purposes. 
There were slight differences between the mechanical properties 
of the RV elastomers compared to the RTV elastomers. This has been 
attributed to two major influences: the molecular chain length of the 
polymer chains of HV elastomers is some seven times greater than that 
of RTV elastomers which leads to increased viscous effects, thereby 
improving mechanical performance. It is the contribution of the volu- 
metric concentration (particle size) of silica particles as the filler 
and not the concentration by weight which governs elastomers' mechanical 
performance and their viscosity. These factors have been well demonstrated 
by incorporating some 4% by weight of "Aerosil", silica filler of 
particle size 16 mu, to "Silastic 382", which not only increased the 
viscosity of this polymer prior to vulcanization, but also led to 
improved mechanical performance, 'approximately doubling the modulus 
and tensile strength. As expected there was a reduction in the 
mechanical properties as the apparent percentage of filler within 
"Silastic 382" was diluted with the use of silicone oil. * 
The effect of increasing or decreasing the percentage by 
weight of vulcanizing agent used within "AB 132025" HV elastomer 
* Medical fluid 360 20cs viscosity Dow Corning 
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proved that the optimum requirement to completely vulcanize all the 
sites eligible for cross-linking purposes throughout the polymer 
was a 10: 1 ratio, of polymer to catalyst. ' Both an increase or 
decrease of, the catalyst led to reduced fiechanical performance. 
Increasing the percentage of catalyst possibly led to a fully cross- 
linked elastomer, but with retained catalyst acting something 
similar to a plasticizer by reducing the modulus; whilst insufficient 
catalyst probably led to incomplete vulcanization of all these eligible 
sites. 
Table 9 
Silicone 
Elastomer 
Tensile 
Strength 
Tear 
Strength 
Total 
Points 
Polyshield 4 5 9 
HV 25 5 3 8 
AB 132025 0 2 2 
Mollomed 2 1 3 
Silskin 3 4 7 
Silastic 382 1 0 1 
The highest number of points were given to the facial 
prosthetic elastomer which gave the best mechanical performance 
data for the corresponding physical property, with a progressive 
decrease of points allocated to the elastomer as the properties 
decreased. (Table 9). 
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Polyshield has been found to be a useful Elastomer for the 
prosthesis that requires less flexibility. ' In some prosthetic 
restorations the bridge of the nose requires a firm base, if the patient 
wears spectacles. Also, the backing of a large prosthesis may be 
required to provide support for the more resilient mass of the restor- 
ation, and provide support over. a wide area of skin contact. 
The HV 25, with its high tensile and .. tear strengths, 
has 
been found an advantage in undercut tissue areas. The elastomer 
alows fine margin production and easy removal from the mould chamber 
during laboratory procedures. 
AB 132025, has low physical characteristics and as such 
limited application to facial prosthetics. A role has been found for 
this elastomer as a temporary prosthesis and short-term applications. 
Mollomed has a satisfactory tensile strength but a low tear 
strength. Particular care is required during laboratory procedures 
to avoid damage to a prosthesis.. The design of mould is of importance 
with the low tear strength elastomer to avoid damage to margins of 
the prosthesis. The life of the prosthesis in clinical use will also 
be limited due to user damage by the patient. 
Silskin has proved to be a most satisfactory Elastomer 
which is accepted well by the patient in terms of clinical application. 
Although from this'investigation it has been found to have a lower 
tensile strength than Polyshield and HV 25 Elastomers it is well 
within the parameters of clinical requirements. Tear strength is 
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good in relation to Polyshield and greater than that of HV 25. 
This physical characteristic allows for good margin integrity and 
handling properties both in the laboratory and patient use. A 
particular advantage of Silskin is its versatility of vulcanization 
(i. e. oven, water bath and room temperature). This three-way 
vulcanization is of great importance in a busy National Health Service 
Prosthetics Centre. A prosthesis can be constructed within the day, 
resulting in cost savings to the treatment programme. 
Colour simulation is very good and pigments mix well in 
the Elastomer base (Table 2). Patient acceptance is difficult to 
define in measurable terms: however all the patients who have pro- 
sthetic restorations constructed from Silskin speak well of it with 
particular reference to comfort, feel and general usage. Silskin now 
forms the main prosthetic silicone Elastomer used in this plastic 
surgery unit. The Elastomer Silastic 382 is confined to room temper- 
ature applications. The low tensile and tear strength of the vulcanized 
elastomer limits its use to temporary prostheses, although the elastomer 
has the advantage of rapid vulcanization (10 - 180 minutes). Silastic 
382 can be effectively used as a resilient core filler in large self- 
retained facial restorations, in particular the orbital area. In 
such applications the low tensile and tear strengths are of no import- 
ance in the final form. Silastic 382 has found an application in 
small area prosthetic reconstruction in particular during stages of 
surgery. 
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PART II CLINICAL APPLICATIONS 
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CLINICAL APPLICATIONS 
The laboratory of the department of Plastic and Maxillo- 
Facial Surgery was formed in 1960 at St. Luke's Hospital, Bradford. 
The Facial Prosthetics Clinic was also established in that year. 
The number of patients referred for prosthetic reconstruction 
has increased each year to a figure of over 300 patients. The 
prosthetic treatment of the patients is further enhanced by the con- 
tinued review and maintenance of patients on the clinic list. 
The main areas of referral derive from plastic surgeons (70%), 
ear, nose and throat surgeons (12%), ophthalmic surgeons (10%), 
and other surgical specialities (8%). The cases referred cover a 
wide range of facial and body defects each with its own individual 
problems and history. 
To produce a satisfactory prosthetic restoration each 
patient must be regarded as a different problem with distinct 
peculiarities, advantages and disadvantages. The individual character- 
istics of these patients require careful selection of the materials 
used. Plastic and reconstructive surgeons of today are well aware of the 
values and limitations of prosthetic materials. They are also aware 
of the limitations of surgical reconstruction. 
The decision to use prosthetic reconstruction shows commit- 
ment and confidence in this form of treatment both as a permanent or 
temporary measure. RANK (1953) describes the attitude towards facial 
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prosthetics, "Plastic surgeons so frequently regarded as agents of 
the supernatural need a strong sense of perspective and responsibility 
in managing the number and variety of patients nowadays referred to 
them. The patient who has endured much is not properly rewarded by 
some ugly daub for a nose, some hopeless excrecence for an ear, or an eye 
region he prefers to cover by a patch or unattractive glasses ... 
One refers rather to the use of prosthetics by choice for certain 
defects simply because it has more to offer the patient than has 
plastic surgery which we well appreciate but the lay public does not. 
Critical consideration of surgical probabilities rather than wishful 
thinking of possibilities should in due humility and without any sense 
of shame lead us to advise a prosthetic restoration for many cases' ... 
The materials examined and developed in this research have 
found wide clinical application in this centre. The volume of cases 
has enabled the prosthetic elastomer bases used to be subject to 
stringent patient evaluation. 
Often on review of a particular patient the prosthesis in 
use would indicate a change of material. Problems have developed 
because a patient now lives in a different environment, or has a change 
of employment. A very hot climate makes the method of retention a 
consideration since certain adhesives are less effective due to per- 
spiration. The prosthetic elastomer may need to be changed to function 
effectively with a different. adhesive. A change of prosthetic material 
may be required due to dusty manual work conditions. These, together 
with the trauma of patient handling, indicate. a possible alternative 
prosthetic elastomer, the -selection being based on the physical 
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characteristics described in this research. 
Women have been found to accept a prosthetic restoration more 
readily than men, and complain less regarding general prosthetic 
limitations. 
In this respect women are less vain, accepting explainable 
problems of prosthetic reconstruction. Because of the care a woman 
gives to the use of a prosthesis, a material can be selected with less 
physical characteristics with more emphasis on aesthetics. The 
advantage of cosmetics available favours the female, patient. A 
limited range of non-perfumed cosmetics for male use are now being 
used to cover skin blemishes (Cosmetic Camouflage). 
The prosthetic elastomers described in this research have 
been used extensively on other parts of the body.. The elastomer 
Silskin with its characteristics and versatility of application is 
ideal for body prosthetic reconstruction. A particular area of 
success is that of nipple-areola complex following breast recon- 
struction. This prosthetic application is now becoming widely used 
in plastic surgery. Indications for this technique as an alternative 
to surgical reconstruction are low cost, no hospitalisation and con- 
sistent aesthetic results. 
The following selected case reports are described to indicate 
avaºtable 
the application of they prosthetic elastomers.. The principal 
objective in each case has been to restore the defect, improve 
aesthetics and re-establish the self-confidence of the patient. 
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CASE REPORTS 
Case 1 (Fig. 21) 
A 68 year old male retired mill worker. Defect: total loss 
of left ear following excision of epithelioma. The tragus has been 
retained as a location point for a prosthesis. The patient was not 
suitable for surgical reconstruction due to age and general health. 
He is an active man who enjoys gardening and plays bowls. 
His skin complexion indicates his outdoor interests. Silskin 
prosthetic elastomer was selected for the prosthesis and pigmented 
to simulate the patient's basic skin shade. Particular attention 
was given to colour match the areas of vascular concentration. 
No external tinting was required. The tragus was a useful aid to 
the patient in positioning the prosthesis. He did not wear spec- 
tacles and had no wish to do so. Retention of the prosthesis was 
by polydimethyl siloxane contact adhesive applied to the fitting 
surface of the prosthesis. The patient reports no problems with 
the prosthetic restoration and is very pleased with the result. 
Review every twelve months. 
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Figure 21 
Case 1 
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Case 2 (Fig. 22) 
A 69 year old farmer. Defect; total right ear removed 
following excision of basal cell carcinoma. Prosthetic reconstruction 
considered the more satisfactory treatment programme in relation to 
health and age of patient. Immediate prosthesis required due 
to social commitment (getting married). Silicone Elastomer AB. 132025 
used first for temporary restoration. Information obtained from 
this temporary prosthesis regarding skin shade, and patient attitude 
to the restoration. The prosthetic Silicone ElastomerAB. 132025 
was pigmented to basic skin shade. Heavy pigmentation characteristics 
could be simulated. Retention was by means of polydimethyl siloxane 
contact adhesive. Patient managed the prosthesis well. On review 
at five weeks a small linear tear in the anterior margin of the 
prosthesis was noted. Patient reported this had occurred during 
cleaning the prosthesis. The temporary prosthesis (AB. 13205) was 
worn for four months. New and final prosthesis was constructed in 
Silskin prosthetic elastomer to prerecorded shade data. Some 
external tinting applied to emphasize fine pigment characteristics. 
Patient and bride pleased with result. Review every twelve months. 
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Figure 22 Case 2 
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Case 3 (Fig. 23) 
A 70 year old retired textile worker. Defect; new 
nose required following excision of basal cell carcinoma. Patient 
referred by general practitioner following consultation regarding 
a skin rash caused by the patient wearing a nose prosthesis con- 
structed in aluminium and coloured by oil paint. The prosthesis 
was made by an ophthalmic company and the patient had worn this for 
nine years. Skin patch tests confirmed the patient's skin reaction 
to the metallic base. No reaction was noted to silicone elastomer. 
The patient was advised to discard the aluminium prosthesis and no 
prosthesis was worn for two months. The skin condition improved 
and prosthetic treatment commenced. To enable the patient to adapt 
to a resilient prosthesis the prosthetic elastomer Molomed was used 
pigmented to base skin shade as a temporary restoration. Patient 
managed the prosthesis well. Prosthesis retained by Polydimethyl 
Siloxane contact adhesive. Provision for spectacles in the 
prosthesis allowed for removal and gave support. Patient progressed 
well. Molomed temporary prosthesis warm for three months. Final 
prosthetic restoration constructed in Silskin. After some 
revision of shade characteristics the patient was pleased with 
result, and his skin condition has improved. Review every twelve 
months. 
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Figure 23 Case 3 
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Case 4 (Fig. 24) 
Male 61 years old construction worker. Defect; nose 
removed following excision of basal cell carcinoma. Patient wishes 
to return to his work on a building site. Referred for prosthetic 
reconstruction as a patient unsuitable for surgical reconstruction. 
t 
HV25 prosthetic elasomer selected to maximize the undercut areas 
ti 
of the defect and provide stability. HV25 pigmented to basic skin 
shade with particular reference to vascular concentrations. Patient 
wears spectacles, and hence provision made in prosthesis to locate 
spectacle bridge. Retained by means of Polydimethyl Siloxane contact 
adhesive. Patient reviewed at four weeks, he reports good progress 
and is pleased with results. Minor points of ulceration corrected by 
reduction of HV25 elastomer. Patient manages the prosthesis well, 
and can carry out his employment without difficulty. HV25 considered 
a satisfactory material for the patient with regard to his work 
environment. Review again in twelve months. 
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Figure 24 Case 4 
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Case 5 (Fig. 25) 
Male 58 years old, electronics engineer. Defect; total 
removal of nose and upper lip area following excision of basal cell 
carcinoma. Lip and nasal margin repaired by means of forehead flap. 
No further surgical reconstruction considered. Referred for prosthetic 
restoration. Silskin prosthetic elastomer, pigmented to simulate 
patient's basic skin shade, was selected for the prosthesis and the 
treatment plan was to include simulation of the patient's moustache. 
Hair was taken to produce the moustache on Dacron mesh base. Patient 
wears spectacles at various times during his work. Provision made 
in prosthesis to support bridge of spectacle frame. Retention by means 
of Polydimethyl Siloxane contact adhesive. Moustache bonded to 
Silskin prosthesis with Cyanoacrylate 413. The moustache masks 
the defect of the upper lip and margin of the prosthesis. Particular 
use has been made of the naso-labial folds to blend the margins 
of the Silskin prosthetic restoration. On review at four weeks patient 
has no problem in management of the prosthesis. He is very pleased 
with the result and has been complimented by his friends. With 
this confidence he has returned to his employment. Review again 
in twelve months. 
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Figure 25 Case 5 
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Case 6 (Fig. 26) 
Male, 60 years old butcher. Extenteration of right 
orbital area for malignant neurilemoma. The extensive defect 
involved the associated maxillary cavity. Referred for prosthetic 
reconstruction. Some collapse of facial tissue in molar region 
due to resection of maxilla. Treatment planned to first restore 
contour and dental function. Obturator constructed with hollow 
bulb extension to restore facial contour and provide support for 
eye and orbital prosthetic restoration. Dental obturator worn for 
four weeks to establish comfort and function. Some sore points 
corrected during that period. A Silskin prosthetic elastomer 
prosthesis was constructed of pigmented material to simulate patient's 
basic skin shade. Facial prosthesis designed to fill orbital cavity 
and interface the dental obturator maxillary bulb. The cavity area 
of the Silskin prosthesis was filled with Silskin 382 to provide a 
resilient lightweight restoration. The prosthetic eye unit is remov- 
able for cleaning and for transfer of duplicate prostheses. The 
upper orbital margin incorporates an eyebrow produced fan the patient's 
own hair and constructed on Dacron mesh base. Eyebrow bonded to 
Silskin by Cyanoacrylate 413. Silskin Prosthetic Elastomer prosthesis 
retained by polydimethyl siloxane contact adhesive on peripheral 
margins of prosthesis. Patient wears spectacles and on review at 
four weeks is managing both obturator and facial prosthesis well. 
He is very pleased with result and now works part-time. Review again 
in twelve months. 
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Case 7 (Fig. 27) 
Female 60 years of age. Extenteration of right eye and 
orbit for ophthalmic tumour. Cavity skin lined. Patient 
referrred for prosthetic reconstruction to renew her current prosthesis. 
She had worn a hard acrylic (Polymethyl Methacrylate) prosthesis for 
five years. The prosthesis was attached to her spectacle frame for 
retention. The acrylic prosthesis had deteriorated and required 
replacement. As part of the treatment plan Polyshield HV prosthetic 
elastomer was selected for the replacement prosthesis. The patient 
requested a material which was less flexible than the other prosthetic 
elastomers available. She had become used to the rigid properties 
of the first prosthesis. Polyshield HV was considered a compromise 
in material characteristics. The patient has obtained new spectacles. 
The defect margins are contained in the front view by the frame of the 
lens. This advantage was used to enhance the aesthetics of the new 
prosthesis. Polyshield HV prosthetic elastomer was pigmented to 
simulate the patient's basic skin shade. The eye unit is removeable 
for cleaning and future transfer to duplicate prosthesis. Eyelash 
provided to eyelid rim. Restoration retained by Polydimethyl 
Siloxane contact adhesive on periphery of prosthesis. On review at 
four weeks patient reported problems in using the adhesive. Further 
tuition given. Patient very pleased with result and commends the 
feature of being able to remove the spectacles and leave the 
prosthesis in position. On review at twelve months patient very 
happy and confident with prosthesis. 
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Case 8 (Fig. 28) 
Female 57 years old. Extenteration of eye and orbit for 
malignant melanoma. Patient referred for prosthetic reconstruction 
with the request for a temporary covering for the defect. This was 
to observe the defect site in consideration of future surgery. 
Temporary cover plate constructed of AB 132025 prosthetic elastomer. 
Following a satisfactory report at nine weeks a permanent prosthesis 
was indicated. The prosthetic elastomer Silskin was selected and 
pigmented to simulate the patient's basic skin shade. To complement 
retention and location an undercut area in the supra orbital crest 
was used. The eye unit is removeable for cleaning and future 
transfer of duplicate prostheses. An eyelash was bonded to the 
rim of the eyelid. Prosthesis retained by the topography of the 
orbital cavity supplemented by Polydimethyl Siloxane contact adhesive 
on periphery of prosthesis. Patient wears and interchanges spectacles. 
On review at four weeks patient reports some pressure in area of 
extension into undercut area. The extension reduced to avoid this 
problem. Patient very pleased with result and has been complimented 
by family and friends. She has renewed her social life with confidence. 
Review every twelve months. 
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Figure 28 Case 8 
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Case 9 (Fig. 29) 
Radical mastectomy, patient 33 year old nurse. Left breast 
reconstructed by use of Silicone elastomer tissue expander, 
850 cc 
size. Following a programme of Saline injections required expansion 
achieved to 510 cc. Tissue expander replaced with 440 cc Silicone 
gel filler breast implant. Post-operative contour satisfactory. 
Patient referred for prosthetic reconstruction of the left nipple- 
areola complex. An impression was recorded of the companion right 
side nipple-areola complex. Sodium Alginate impression material 
used. Shade data and pigmentation characteristics of areola were 
recorded for laboratory procedures. Silskin prosthetic elastomer 
was used to construct an individual anatomical replica nipple-areola 
complex. The prosthesis is retained on the breast by means of 
Polydimethyl Siloxane contact adhesive. Patient instructed in 
management of prosthesis. Very happy with result. Review at six 
months. 
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Figure 29 
Case 9 
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Case 10 (Fig. 30) 
Radical mastectomy, patient 46 years old. Right breast 
reconstructed by use of Silicone elastomer tissue expander 850 cc 
size. Saline injection programme completed to required expansion 
of 1090 cc. Tissue expander replaced with 700 cc Silicone gel 
filled breast implant. Post-operative contour satisfactory. Patient 
provided with a standard commercial nipple prosthesis (Fig. 31). Not 
happy with appearance, following a brief period of wear declined to 
use this prosthesis. Referrred for individual prosthetic reconstruction. 
Impression recorded of left companion nipple-areola complex using 
Polysulphide rubber impression base. Shade data and individual 
pigmentation of the areola were recorded for laboratory procedures. 
Silskin prosthetic elastomer used to reconstruct the nipple-areola 
complex. Prosthesis retained in position by means of Polydimethyl 
Siloxane contact adhesive. Patient instructed in management of 
prosthesis. She is very pleased with the result and reports sea 
bathing on holiday with the prosthesis securely in place. Review 
at six months. 
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Figure 31 Prosthetic Nipple-Areola complex prostheses. 
Prosthetic Elastomer: - (SILSKIN) (a) contrast 
with standard commercial prosthesis, (b) anatomical 
and aesthetic characteristics of SILSK1N elanLomer. 
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Figure 32 SILSKIN prosthetic elastomer used 
as a cosmetic covering for a 
myoelectric hand prosthesis 
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PART III ADHESIVES 
102 
There are agents in nature able to make bodies stick together by 
very strong attraction and it is the business of experimental 
philosophy to find them out. 
Sir Isaac Newton 
1718 
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INTRODUCTION 
Prosthetic Adhesive 
An important requirement in facial reconstruction by 
prosthetic means is the selection of adhesives which must provide 
functional retention, be hygienic, non-inflammatory and non-allergenic. 
The adhesive must be simple to apply and easily removed, be inexpensive 
and readily available in stable form. Over the years many adhesives 
have been developed in the form of proprietary formulations. This 
practice continues with products that do not indicate the composition 
of the adhesive, a feature particularly evident in the many forms of 
adhesive dressing materials for the skin. The dressing type adhesive 
needs only to serve a short-term, one-time application to human skin 
and as a thin layer to provide protection against external bacterial 
infection during primary wound healing. 
In respect of facial prosthetics a speical need exists for 
developing an adhesive formulation with well characterized components. 
In contrast to that of the one-time use dressing adhesive is the rep- 
eated priming and removal from the prosthesis and skin surface. This 
involves a complexity demanding interactions at the (a) prosthesis- 
adhesive and (b) adhesive-dermal interfaces with the exudates from the 
skin that interfere with the adherence. In Part III the factors 
involved in the selection, formulation and application of adhesive 
compounds for wound closure and adhesives specific to facial prosthetics 
termed surgical adhesive for wound closure and external adhesive, are 
examined. The fundamental, physical and chemical concepts of adhesion 
are investigated from which the compounds and their functional criteria 
can be determined. 
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The human skin is the interface for which the applied 
adhesive must be formulated to provide the necessary adherence of 
reasonable duration from several days to several weeks. In the 
chemical sense, the principal substrate is the insoluble protein 
keratin along with the continuous extruding perspiration comprising 
chemical metabolites (Table 10). In the deepest layer of the 
epidermis new cells are formed by mitosis and these constantly push 
outward and take the place of the keratinous cells that are sloughed 
off. This layer can be readily penetrated by aqueous media and by 
low molecular weight solvent, and esters: it is the first line of 
sensitivity to such components contained in the external adhesive that 
results in inflammatory responses. This provides the early indication 
that the fomrulated adhesive should avoid these additives in particular 
when using thinning or diluting agents. 
Sweat glands and their ducts push outward from the dermis 
and through the epidermis to the surface of the skin discharging the 
metabolites (Table 10) which, in varying degrees, affect the durability 
of the adhesion. The most active exudates in this respect are water, 
lactic acid and lactates, lipids, and urea which are strong hydrogen- 
bonding substrates that work against the keratinous epidermal surface 
and thereby cause breakdown of bonding at the adhesion interface 
LONTZ (1960) (unpublished paper). 
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METABOLITE COMPONENTS OF HUMAN SWEAT 
Electrolytes mg/100 ml 
pH 
Sodium 
Potassium 
Calcium 
Chloride 
Bicarbonate 
4.5 - 7.5 
24 - 312 
21 - 126 
5- 32 
36 - 468 
0- 23 
Nitrogen metabolites 
Amino acids (10) as NPN 
Urea 
Nictotinamide 
Other 
Lactic acid (lactates) 
Glucose 
Lipids (varied oils, etc. ) 
24 - 64 
12 - 57 
trace 
1- 30 
1-3 
0- 30 
Sweat exudation 300 - 700 ml/day 
LONTZ (1960) Table 10 
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Chemical types of external adhesive 
Adhesives in a wide variety of form and application have 
been used for almost every conceivable application from structural 
engineering to medical and surgical adhesion. Adhesives formulated 
for expected or specific durability such as medical applications must 
be cleared for toxicity and allergic reactions. A classification 
of adhesives based on the chemical characteristics of polarity is 
summarised in (Table 11. ) 
Classification in terms of degree of polarity is one of 
practical convenience in the identification of hydroxyl and carboxyl 
groups; their absence or presence in high or low proportions is a 
means of distinguishing the extreme range. Exudates from skin vary in 
extremes of polarity, formulations comprise mixtures of these extremes 
to accommodate the principal physical forms that provide adhesion. 
The principal forces are dependent upon the forces of hydrogen-bonding 
which is displacing the classification of polarity, especially since 
hydrogen-bonding can be used as the criteria of adhesion forces and 
strength LASSETTRE(1940). 
Adhesion mechanisms and factors 
The generally accepted concepts of mechanism and factors 
contributing to adhesion between two substances are based on inter- 
molecular forces SCHMIDT(t948). Foremost is the concept of what 
forces or energy are available at the surface and can this energy be 
concentrated at the two interfaces relevant to facial prosthetic 
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CHEMICAL CLASSIFICATION OF ADHESIVES IN MEDICAL USE 
Polarity Chemical Type Selected Examples 
Low (a) Hydrocarbons Hydrocarbon gums 
Hydrocarbon elastomers 
(b) Halogen hydrocarbons Chloro-elastomers 
Chloro vinyl polymers 
Medium (a) Nitrogen, sulfur, Nitrile elastomers 
silicone-containing Thipolasts 
(b) Oxygen-containing Rosin, shellac, acrylics, 
phenolic, acetals 
High (a) Oxygen-containing Starches, dextrin, plant 
gums 
Cellulose ethers and esters 
Polyvinyl alcohol 
(b) Amide and amine Protein 
Casein 
Polyamides, urea and 
melamine resins 
Table 11 
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retention in the model (Fig. 33), namely the surface interface pros- 
thesis - adhesive and concurrently adhesive - skin. 
Phase 1 and 5 
are the solids joined, 2 and 4 are their surface layers and 3 is the 
adhesive film between them. If a pull in the direction of the arrows 
is applied to the joint the rupture starts at a point where the local 
stress exceeds the local strength. If a stress, at a first approx- 
imation is considered to act along the axis of the joint it gives way 
along its weakest cross section. BICKERMAN (1958) describes the 
adherence in terms of surface energy. 
A molecule in the interior of a stable solid is surrounded 
on all sides by other similar molecules so that the intermolecular 
attraction is, on the average, balanced and the same in all directions. 
On the surface, the attractive force is unbalanced because of the 
boundary phase, that is, a smaller number of molecules. The surface 
molecules are subject to an inward, hence adherent attractive, i. e. 
with available surface energy. From this one can summarise that like 
molecular configurations between the surfaces at the interface should 
provide the needed mutual adhesion, namely, the facial prosthesis- 
adhesive interface as one formulation and the adhesive-skin the other, 
but with a common attribute or third component identifiable with 
tackiness. 
Tackiness 
When applied to an adhesive, it means the resistance which 
must be overcome to separate two solid adherents between which there 
is an adhesive still in the fluid, mobile, liquid state. 
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4 
Figure 33 Schematic view of an adhesive joint, 
1 and 5 the adherends, 2 and 4- interfacial layers, 
3- the adhesive film. In a tensile test force is 
applied in the direction of the arrows. 
After BIKERMAN (1958) 
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The concept follows by consideration as shown in Schematic 
Fig. 34 of two circular models, A (prosthesis) and B (the skin) 
between which there is a layer of liquid or deformable adhesive (C) 
bulging out of the periphery with an initial thickness. The force 
(F) necessary to separate the two interfaces in an interval of time 
has been proposed by STEFAN (1874). This is that the force required 
to separate two solids between which a liquid layer is present is 
inversely proportional to the duration of its action. The force is 
necessary not to overcome an attraction between solids or between a 
solid and a liquid but to impart to the liquid layer the speed deter- 
mined by speed of separation. Therefore it is proportional to the 
viscosity of the liquid. If A is lifted from the support B by force 
F and if t is the time spent in raising the distance between A and B 
from hl to h2 then: 
Ft=3mýa4 1_1 
4h h2 
If the adhesive layer originally (that is, before separation) 
was very thin and the experiment continued until complete separation 
of A and B occurred, then 1/h22 can be neglected in comparison with 
1/h1. From the experimental value of Ft the original clearance hl 
2 
can be computed, and this magnitude used for estimating the solid 
surfaces in contact. 
An adhesive for facial prosthesis must have adhesion on 
contact: however this can deteriorate or lose adhesion in hours or 
even minutes out of the province of the Stefan equation. For facial 
J 
prosthetic application, the patient would require to have the 
adherence for several days and possibly several weeks, presuming 
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A 
Figure 34 Schematic: Stefans experiment, resistance to overcome 
two adherent surfaces. (A) prosthesis lifted by (F) 
(B)'skin (C) adhesive. 
J 
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that personal hygiene is maintained. The hypothesis is that standard 
force-time (Ft) values be used for both the prosthesis-adhesive inter- 
face and the adhesive-skin interface, the two of which may be different. 
It is evident that the viscosity component (n) in the above equation is 
highly important to ensure anatomical confirmation and needs to be 
optimized to make sure that failure at the respective interface is not 
due to stress rupture but rather to flow. 
General concepts for facial prostheses adhesion 
In the case of prosthetic fixation to living tissue, adhesion 
is a complex involvement of two surface conditions namely, a highly 
polar skin substrate with an abundance of oxygen-containing entities, 
notably hydroxyl, carboxyl and amide groups on the one hand and 
relatively low polarity with an insufficiency of hydrogen-oxygen con- 
taining groups. The exceptions are the interchain non-polar oxy 
linkages such as are included in plasticizers for polyvinyl chloride and 
the chain structure of polysiloxane. The adhesion from a 
chemical sense has to provide for an interlayer for the adhesive, 
selected and formulated (Table 12) to accommodate each one of the two 
dissimilar surfaces, namely living tissue and the facial prosthetic 
material. These two dissimilarities are described as hydrophilic 
or water-wetting for the living tissue, and hydrophobic water non- 
wetting for the prosthesis, a distinction that originates with the 
fundamental physical characteristics namely surface tension and 
ultimately the tendency for hydrogen binding. In the latter feature 
the extent of the active hydrogen bonding can be readily ascertained by 
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infra-red spectrometry. These features along with a 
quality described as tackiness provide sufficient information for 
formulating adhesives that should serve adequately for topical skin 
adherence of reasonable time duration. Formulation of an adhesive 
serving the dual function'of adherence to the facial prosthesis and 
adherence to the living tissue is the matter of compounding all three 
types of the polar groupings indicated in Table 11 in their correct 
proportions for the various facial prosthetic materials Used and 
individual patients concerned. 
Forces working against adhesion 
From the time an adhesive is applied to the respective 
surfaces there are forces initiated and increased which work against 
the adherence and ultimately cause detachment of the prosthesis from 
the skin. These can be considered in terms of (a) adverse chemical 
effects due to exudates or sweat from the skin (Table 10) and (b) 
mechanical or tensile difference of the facial prosthesis and adhesive 
with relatively extensible skin whose biochemical properties must 
approximate, in the initial stress-strain profile, that of living 
tissue. 
Adverse Chemical Effect 
The principal adverse effect can be credited to the accumulation, 
at the interface of the polar compoents, of sweat, thereby moving the 
force potential of the adhesive from the skin to a built up layer of 
the sweat and exudate metabolites. The relatively high hydrogen bonding 
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affinity of the components of sweat, especially the water which may 
vary from 0.2 to 2.0 grams per day along with the lactic and amino 
acids. This coupled with the increasing accumulation at the interface, 
can only result in progressive weakening of the adhesion and eventually 
complete detachment of the facial prosthesis. An important requirement 
for an adhesive formulation is to include sufficient amount of water- 
imbibing or hygroscopic ingredient to absorb the expected level of the 
exuding water and internal moisture to predicted levels BULBULIAN (1973). 
Such compounds can be the soluble high polarity group such as cellulose 
carboxymethyl cellulose, and polyvinyl alcohols, which are commercially 
available and in specified grades, approved for medical applications. 
Viscoelastic Requirement 
The adhesive formulation must be as indicated by the Stefan 
equation (see above, page 110), or visco-elastic component and one 
compatible with the low polarity prosthetic material substrate. This 
formulation will provide adherence, and also retain the viscous or visco- 
elastic characteristic. These requirements for the facial prostheses 
single out viscous hydrocarbons, one example of which is the commercial 
polyisobutylenes LONTZ. (1969). The gum compounds have a high degree 
of tackiness and remain unchanged by the metabolic exudates and provide 
the criterion of flow movement according to the Stefan equation with 
the important factor of viscosity, which for successful, functional 
retention should be in the range of 3,000 to 10,000 cP. Since gum 
compounds are usually much higher in viscosity, an addition should 
include low voscosity hydrocarbons to reduce the viscosity of the hydro- 
carbon gum for functional use. 
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The resulting formulation of the low-polarity compound now 
provides a stable interface having in addition to the thickness, now 
more appropriately described as pressure-sensitive adhesion, the 
feature of low viscosity and high-low modulus. The latter enables 
the intervening adhesive layer to conform to the initial, tactile 
modulus or viscosity of the skin and with the facial prosthesis. 
The prosthesis material must have a low modulus, in the range of 3 to 
8 kilograms per square centimeter, in order to provide its conformity 
with the elasticity of the adhesive and of the skin. 
The adhesive formulation should not change in consistency 
on aging which often occurs with certain medium polarity adhesives 
notably shellac, rosin, and certain acrylics which have a strong 
tendency to harden by oxidation or auto-polymerization. 
Formulation 
The compound formulation (Table 12) often found in adhesive 
surgical dressings and tapes, can be used to increase the adhesion 
for a specific prosthetic material and for the differences in the 
skin exudates of different patients. For example polyvinyl chloride 
plasticized facial prosthesis can be expected to require a different 
balance of the low and high polarity additives compared to poly- 
siloxanes (silicones) and polyurethanes. Also, the type of plasticizer 
usd in polyvinyl chlorides will dictate adjustment in these two 
principal components. In addition, modifiers and thinning ester 
solvents, innocuous to human skin may be included along with pleasant 
odorants. In some cases, topical anaesthetics especially for easily 
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sensitive skins may also be included. The final requirement is that 
of the ease of removing expended and oxidised adhesive along with 
any sebaceous debris. A cleaner formulated of non-irritating solvents, 
-j , RICH&. oRo& INANE SSOPAOPANOC. 
such as ar Iseprcpanol-formulation, is the most effect- 
ive for most external adhesives. 
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Tissue adhesive 
For some 2,000 years the union and closure of human tissue 
has been achieved by means of needle and thread. Many types of lig- 
ating materials have been employed with varying success. These have 
been primarily natural products such as cotton, wood-fibre, linen and 
animal sinews. 
In modern surgical science synthetic materials such as Nylon 
and Dacron have gained importance. During the past twenty-five years 
surgeons have become increasingly interested in replacing and augmenting 
conventional sutures by means of adhesive bonds. 
There are several reasons for this clinical interest. COOPER 
& FALB (1968) indicate the advantages as: (1) The potential rapidity 
with which tissue union can be achieved; (2) the ability of a bonding 
substrate to effect complete tissue closure, thus preventing seepage of 
body fluids; (3) the advantage of forming bonds without deformation 
of the tissue; (4) the possibility for improvement in the repair of 
tissue effected by age and disease where suture methods are difficult; 
(5) the ability to effect tissue closure in inaccessible areas of the 
body. 
BAKER (1984) describes the conventional suture of facial skin 
as the 'Zipper effect' (due to the needle puncture pattern on either 
side of the wound) with the consequential poor aesthetic results. This 
effect is absent when adhesive closure is used and is of obvious value 
in 
cosmetic surgery. 
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The first instant-bonding adhesive, an acrylate polymer, was 
formulated unintentionally in 1941 by Eastman Kodak Co. USA, when 
experimenting with clear acrylic monomers as possible materials for 
gunsight lenses. 
Cyanoacrylate was found to have the right optical properties 
but also found to adhere to everything in contact with it. In the 
presence of humidity the liquid turned into a strong adhesive. Cyano- 
acrylate remained a laboratory curiosity in research and development. 
After the war the unique bonding qualities of the polymer were recog- 
nised and the adhesive became available for industrial use (ARDIS 1949) 
and has since been documented extensively in chemistry literature. 
COOVER et al. (1959), LEONARD et al. (1966), GRODE et al. (1970). ' 
Since the early encouraging reports on the use of tissue adhesives in 
surgery by NATHAN et- al. . (1960), STRAATSMA at al. (1963), ELLIS & LEVINE 
(1963), 
-an extensive range of clinical applications has been reported in 
the medical literature (1960-1987) = 441 papers. Most of the major 
surgical specialities report the use of cyanoacrylate as a , tissue adhesive. 
Selected examples are described below. 
Otolaryngology 
KOIDE (1965) reported the use of biological adhesive for 
reconstructive surgery in the middle ear. WATSON & MAGUDA (1965) used 
a trilene-di isocyanate of acrylic acid in tympanoplastics for constructing 
columellae and interpositions. FUJIWARA et al. (1966) reported good 
results in eight cases of reconstruction of the auditory ossicle chain 
using a formulation of methyl cyanoacrylate and nitrile rubber. 
VYSLONZIL (1969) reported the successful reconstruction of the incudo- 
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stapedial joint using butyl-2-cyanoacrylate in tympanoplasty, also 
in cases of decompression of the facial nerve with temporal removal 
of the incus. DECHER (1971) reported 57 cases of conglutination by 
means of butyl-2-cyanoacrylate, which showed good average results. 
SCHNIEDER (1972) reports 123 cases of middle ear reconstruction using 
butyl cyanoacrylate. He indicates that to obtain satisfactory results 
the application of the adhesive must be kept to small amounts delivered 
already used by SCHIEDcR in W72. 
means of an applicator. / Results of healing and restoration of 
the hearing function were equal or better than those achieved by standard 
methods of tympanoplasty. 
Plastic Surgery 
OUSTERHOUT et at. (1971) used butyl cyanoacrylate and 
heptyl cyanoacrylate on 40 patients in the treatment of split thick- 
ness skin graft donor sites. Each site was divided and one area 
treated by fine mesh gauze (control), the other with cyanoacrylate 
applied by means of a small spray gun. In 36 of the 40 patients 
butyl cyanacrylate was used. Good results are reported with this use 
of cyanoacrylate. This method of local treatment of split thickness 
skin graft donor sites in comparison to the fine mesh gauze offered 
a saving in time for both surgeon and nursing care. There was a 
decreased loss of blood at the time of surgery, especially. in patients 
with prolonged bleeding times. A decrease in post operative pain was 
noted. 
LEONARD et al. /(1966) indicates that the initial reduction of 
pain at the surgical site may be due to macro-quantities of the cyano- 
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acrylate being absorbed causing a mild local anaesthesia at the distal 
nerve endings. 'In both the control and cyanoacrylate sites the 
healing 
time was approximately the same. Eighty-two per cent of the patients 
treated preferred the cyanoacrylate method of local treatment of split 
skin donor sites. 
There was no evidence in this study to suggest antigenic 
properties of cyanoacrylate and none of the patients in this series 
demonstrated any form of allergic reaction. 
e&ck repor%d (Luse of 
BROMBERG et al. (1964) and STONE (1966)/ methyl-2-cyanoacrylate 
to fix skin grafts, and each reported satisfactory results. ROBERTS (1976) 
reports the use of butyl cyanoacrylate in the treatment of 18 patients 
following acute burns and for reconstruction of burn contractures. 
ROBERTS conducted a series of in vitro experiments of both sutured joints 
and cyanoacrylate joints. The adhesive bonded joint was found to be 
stronger in thin skin grafts. The adhesive-joined skin was approximately 
equal for all the skin thicknesses used and equal to sewn joints of 
grafts 0.12 mm thick. The adhesion between the underside of the graft 
and surrounding skin was found to be stronger than that between the. 
edge of the graft and skin. ROBERTS lists the advantages of cyano- 
acrylate as: - (1)rapid time to effect fixation, e. g. some 
10 per cent of 
time taken to make an equivalent sutured joint; (2) no risk of subgraft 
bleeding as may occur during fixation with sutures; 
(3) can be used to 
join pieces, of graft together both when bare and when backed with 
tulle 
gras. This is a particular benefit in tangential excision and grafting 
procedures; (4) graft fixation is made easier if application has to 
be 
carried out on the ward without anaesthetic; (5) no sutures to be 
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removed, as adhesive detaches itself in 2-4 weeks. When used for child- 
ren's hands, this may save a general anaesthetic; and possible chance of 
infection. 
SHARPE (1985) used butyl cyanoacrylate for the fixation of 
skin grafts in burns patients. The adhesive was found to be of 
particular use in 20 burns patients following the Bradford Fire. The 
patients who received skin graft fixation by means of cyanoacrylate are 
reviewed later in the text (3 year review: see page 173). 
SHARPE et al. (1988)also used butyl cyanoacrylate for skin graft 
fixation following the Aberdeen oil rig disaster as an addition to other 
methods of fixation. 
Maxillo-facial and Oral Surgery 
Ne, BHASKAR et al. (1966) _, used butyl cyanoacrylate under a 
wide range of oral conditions. report, the response of surgically 
treated gingiva to butyl cyanoacrylate to be consistently excellent. 
When butyl cyanoacrylate was used on the oral mucosa epithelization 
occured faster than conventional dressings. As the underlying tissues 
healed the adhesive was exfoliated or could be lifted from the area. 
Cyanoaorylate can be used in gingivectomy where it is difficult to retain 
ýae1 
ail 
usual dressings. BHASKAR et al. (l968), report4 fixation of free mucosal 
grafts in the oral cavity and protective covering of oral ulcerations. 
BHASKAR concludes that the use of cyanoacrylate in oral surgery is 
highly promising. 
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AVERY et al. (1982) used butyl cyanoacrylate in 8 cases in 
maxillo-facial surgery. The cases described involved fixation of bone 
to bone, soft tissue and silicone-implants. The adhesive was used to 
locate and bond small bone fragments in-cranio-facial surgery. Methods 
of fixing orbital floor implants constructed of silicone elastomer 
involve stainless steel wires or surgical impaction. AVERY et al. 
used the cyanoacrylate to secure the implant to the floor of the orbit. 
ROBERTS & EASTWOOD (1983) used butyl cyanoacrylate to secure orbital 
floor implants in blow-out fractures of the orbit 
Neurosurgery 
Neurosurgeons have found extensive use for cyanoacrylate 
adhesive for arteriotomies, arterial anastomoses and the encasement of 
aneurisms. CARTON et al. (1962) reported their experimental repair 
with Eastman 910 (methyl-2-cyanoacrylate). They also report the-success- 
ful patch repair of an internal carotid artery. The use of methyl-2- 
cyanoacrylate was discouraged by HOPPENSTEIN et al. (1965), who 
reported thrombosis, of-arteries when this ester was used. Since that 
report neurosurgeons have made more use of butyl cyanoacrylate. - VANDER 
iýeiý " 
ARK et al. (1970) relates - experience in the repair of cerebrospinal 
fluid fistulae with isobutyl-2-cyanoacrylate. He states that the ideal 
adhesive for neurosurgery would have the following properties: (1) no 
toxicity to neural and vascular tissues; (2) strong and rapid bonding 
to bone1dura, facia. muscle and synthetic materials; (3)-ability to bond 
in the presence of blood and cerebrospinal fluid; (4) be simple to apply. 
VANDER ARK found cyanoacrylate useful in neurosurgery where it is 
difficult to maintain a dry field. MAXWELL & GOLDWARE (1973) also reported 
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successful use of isobutyl-2-cyanoacrylate in a wide range of neuro- 
surgical procedures. TINDALL (1983) describes extensive experience 
in sealing cerebrospinal fluid leaks using isobutyl-2-cyanoacrylate. 
ZANETTI & SHERMAN (1973) indicate the feasibility of occluding aneurisms 
by direct injection of isobutyl-2-cyanoacrylate. This technique was 
erred a 
further developed by SHEPTACK et al. (1977) in 20 cases direct 
-For occtW vt arteurissºS, 
injection of isobutyl-2-cyanoacrylate was uee4( Follow-up 6 years 
after operation showed 80% success rate. 
ýI 
Ophthalmology 
Ophthalmic surgery has found frequent use for cyanoacrylate 
adhesive. NAKAGAWA & NONAKA (1964) used butyl-2-cyanoacrylate for the 
reattachment of extraocular muscles. ELLIS & LEVINE (1963) have covered 
thin areas of the sclera with tissue and polymer plates, fixation was 
achieved by means of butyl-2-cyanoacrylate. CALABRIA et al. (1970) and 
HUNG & HILTON (1982) describe satisfactory and encouraging results from 
the use of butyl-2-cyanoacrylate in anchoring an encircling episcleral 
band in retinal detachment surgery. TSE et al. (1984) successfully 
used butyl-2-cyanoacrylate to seal cerebrospinal fluid (CSF) fistulas. 
Intraoperative CSF leakage is an infrequent complication of orbital 
surgery. The risk of meningitis warrants immediate attention intra- 
operatively. TSE et al. describe three cases of sealing CSF leakage 
and report good and effective results. On the application of small 
droplets of butyl-2-cyanoacrylate the CSF leak ceased immediately. 
nhv ed 
SPITZNAS et al. (1973) X report, - an extensive series of the use of 
butyl-2- 
cyanoacrylate in 100 cases of retinal surgery. They had no serious 
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complications attributed to the application of the cyanoacrylate. In 
one patient in the. series the adhesive penetrated through the perfor- 
ation into the vitreous body but did not cause any complication. SPITZNAS 
et al. concluded from their extensive experience that butyl-2-cyanoacrylate 
can be recommended unconditionally as a routine measure for certain situ- 
ations in retinal surgery. Fixation of implants in the orbital area 
are described by TSE (1986). He used butyl-2-cyanoacrylate in 12 cases 
with excellent results in each patient. The rapid polymerization of 
the adhesive proved complimentary to the surgical procedure. The implant 
material used in this series was compression moulded methyl-methacrylate. 
Obstetrics and Gynaecology 
STEVENSON & TAYLOR (1972) used methyl-2-cyanoacrylate in the 
Fallopian tubes in 12 patients. The adhesive was injected into the 
uterus in a trial series'before hysterectomy by means of a modified 
Foley catheter. The patients were women suffering from persistent dys- 
functional uterine bleeding. The technique was free from side-effects. 
STEVENSON and TAYLOR selected methyl-2-cyanoacrylate for its fluidity 
and ability to readily enter the Fallopian tubes. They suggest their 
technique can be developed to control persistent menorrhagia and offer' 
a method of permanent sterilization in women. NEUWIRTH et al. 
(1980) 
also reports the use of 0.6 ml methyl-2-cyanoacrylate delivered to the 
Fallopian tubes by means of the FEMCEPT*device. The women treated were 
prior to hysterectomy and on an ambulatory basis. No significant 
complications or side effects were noted and 78% Bilateral tubal closure 
was achieved in this study. 
*Dispensing instrument for placing drug material into canals of the 
Fallopian Tubes of a female primate. FDA Reg. No. 1187503 
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NEUWIRTH et al. (1983) in a further study of female steriliz- 
ation used a radiopaque methy-cyanoacrylate. The adhesive with its 
radiopaque loading (Barium Sulfate) made it possible to determine tubal 
entry of the methyl-cyanoacrylate, again the FEMCEPT device was used for 
application, satisfactory results are reported. 
The present study 
The leading manufacturer of cyanoacrylate adhesives in the 
Western world today is the Loctite Corporation. This international 
company was approached in 1983 to consider supporting the research poss- 
ibilities regarding the-use of cyanoacrylate in plastic and reconstructive 
surgery. The proposal was initiated by the Professor and Head of the 
School of Biomedical Sciences, University of Bradford. 
Loctite UK have supported this study with particular regard 
to adhesive selection and identity for plastic surgery and prostheses. 
The research has also involved the development of a precision delivery 
method of the adhesive to the surgical site. The cyanoacrylate adhesives 
used in this study are Loctite formulations. 
On the 11th May 1985 the Bradford fire disaster occured at the 
Valley Parade football ground. The surgical skill of the plastic surgeons 
operating in the aftermath of this disaster resulted in many original 
techniques and devices being devised. 
Among these was the use of cyanoacrylate adhesive for skin 
graft fixation. This adhesive enabled surgeons to deal with the volume 
of patients with severe burns in a short time. 
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The experience gained from this period and the subsequent 
rehabilitation of these patients has provided added stimulus for this 
study. 
Cyanoacrylates 
Cyanoacrylates are a homologous series of liquid monomers 
which polymerize when applied to a moist tissue surface and have the 
ability to bond human tissues together. The alkyl 2-cyanoacrylates were 
first recognised to have adhesive properties by COOVER et al. (1959). 
The cyanoacrylates have the general formula LEONARD et al. (1966): 
CN 
CH2 =C 
COO-R 
R= side chain 
The number of alkyl groups in the side chain may be increased from one 
(methyl cyanoacrylate) up to any number but usually no further than 
eight (octyl cyanoacrylate) providing a series of adhesive compounds. 
Cyanoacrylate adhesives differ physically to meet the defined 
application. The main distinguishing feature between the esters is the 
size of the molecule. 
Methyl, the original cyanoacrylate ester, is the smallest. 
A large number of molecules from adhesives with this ester can be 
applied over a given area. Consequently a larger number of polymer 
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chains can be formed resulting in bonds with high tensile strength. 
methyl cyanoacrylate adhesives are by formulation recommended for 
rigid structures. 
The ethyl ester is slightly larger than the methyl, although 
adhesive properties are very similar. However, because of their larger 
size the number of molecules per given area is less than that for methyl 
adhesives. This results in a less rigid adhesive. 
The butyl ester is considerably larger than the methyl or 
ethyl esters. Because of this butyl cyanoacrylate adhesives when com- 
pared with methyl and ethyl based adhesives are slower curing, relatively 
weaker and less volatile. Whilst a slower cure speed has obvious 
advantages to some surgical applications such as alignment of bone and 
soft tissue, it is its low volatility which gives a butyl cyanoacrylate 
adhesive its main advantage. 
The larger molecule is less volatile than the other two esters, 
hence odour from chemical reaction is reduced. A particular feature 
of this ester is that 'blooming' is eliminated. Blooming is the term 
describing a white stain on the bond line caused by the rapid conden- 
sation of cyanoacrylate vapours. This is of importance in surgical 
procedures. 
No particular adhesive häs'been yet formulated that will 
bond everything. Different materials in differing environments require 
considered selection of adhesives. 
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To select the most suitable cyanoacrylate for both medical 
or industrial use requires an understanding of cure and adhesion 
mechanisms. 
Factors which affect cure speed and bond strength can be 
identified and possible bond-failure eliminated. In general terms 
an adhesive must first flow and spread so that it thoroughly wets 
the surfaces to be bonded, penetrating into and filling all surface 
irregularities. It must then change from its liquid state into a 
solid which links the surfaces together. Cyanoacrylate adhesives 
solidify due to their reaction with moisture on the surface of the 
tissue to be bonded. 
Cure Mechanism 
Cyanoacrylate adhesives are maintained in a liquid state by 
an acidic stabilizer (Hydroquinone) which inhibits the molecules from 
cross linking (Fig. 35 & Fig. 36). 
Partly ionised molecules of water which are normally found 
on all surfaces exposed to the atmosphere have the ability to overcome 
the stabilizer (Fig. 37). 
When the cyanoacrylate adhesive is applied to the tissue 
surface the stabilizer is removed, the molecules join and a cure begins 
and is completed in seconds (Fig. 38 & Fig. 39). 
Figure 35 
Acidic stabilizer (red) inhibits Adhesive molecules (white) 
from linking. Partly ionised molecules of water (blue) on 
surface. 
FipurQ 36 
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Figure 37 
Water molecules (blue) have removed the stabilizer and 
cuz'e beginn. 
Figure 38 
Polymerisation chains interlock to bind surfaces of molecules 
together. 
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Figure 39 
Polymerisation chains continue to form, increase and 
interlock to produce bonds with structural strength. 
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CN CN CN 
I 
CN 
CH2 =C +CH2 +C WATER_- CH2 -C -CH 2-C 
COO-R COO-R COO-R COO-R 
The cure mechanism of cyanoacrylate adhesive is affected 
by a number of factors: 
(1) if the ambient moisture content (humidity) is too low 
(below 40-60%). 
(2) if the bond space is too wide for surface moisture to affect 
the cure mechanism. This may relate to bone and tissue approximation. 
(3) if too much adhesive is applied to the tissue surface in 
relation to size of area to be bonded. The cure time in such cases 
is extended, due to polymer mass and moisture penetration. 
(4) excessive deposits of debris on the tissue surface such as 
cream or oil films. The presence of coagulated blood will also 
reduce the effect of the cure mechanism and reduce the bond. 
A cure speed of 10 seconds is ideal for skin tack down in 
respect to skin graft fixation. In cases where tissue approximation 
is needed 20 seconds is a satisfactory working time. Precision 
dispensing allows fast cure times to be exploited. 
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Adhesion mechanism 
Adhesion is achieved by attraction between molecules of 
cyanoacrylate adhesive and molecules of the surface to be bonded. 
The strength of the adhesion relies mainly upon the approx- 
imation of the molecules attracted to each other, the nature of the 
molecule, the physical or mechanical locking and keying action of the 
adhesive into the irregularities of tissue surface. The cyanoacrylate 
penetrates into the interstices of the tissue and becomes immobilised 
by polymerization. 
Bond strength depends on the morphology of the tissue site 
and the preparation of the interface. 
Viscosity 
A wide range of viscosities are available: (3 cP to 10,000 cP). 
Viscosity has been found to be an important consideration in 
clinical application. 
Viscosities below 5 cp give problems of control at the surgical 
site. A cyanoacrylate the very low viscosity range tracks away from 
the point of application. If the viscosity is too high it is difficult 
to dispense in the precision equipment (described later in text). 
High viscosity cyanoacrylate also acts as an interface spacer, 
which is a disadvantage in surgical procedures, e. g. skin graft 
fixation. 
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A viscosity of 120 cp has been found to be ideal in our 
clinical applications. This viscosity enables flow characteristics 
to be maximized with regard to the precision dispensing technique 
developed in this study. 
Haemostatic properties 
Cyanoacrylate adhesives have been found to act as a fast 
and effective haemostatic agent. 
Low-flow bleeding over large surface areas make it difficult 
to use conventional surgical methods of haemostasis. In such cases the 
use of topical haemostatic materials are an advantage and indicated 
ROBERTS (1985). 
The management of surgical bleeding by the use of cyano- 
acrylate isaextensively reported by MATSUMOTO '(1970). He describes 
the role of cyanoacrylate in a range of applications as a haemostatic agent. 
Cyanoacrylate was extensively used during the Vietnam war. 
Used as a fine spray the adhesive is credited as a life-saving agent 
in the first line treatment of critically wounded servicemen with 
uncontrollable haemmorhage MATHISEN (1980). 
The mechanism by which cyanoacrylates achieve haemostasis is 
a matter of conjecture at this present time. It is a hypothesis that 
the cyanoacrylate film causes mechanical blockage to slow the blood 
flow. The adhesive may serve as a surface agent to activate the clotting 
cascade. 
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There is preliminary evidence that cyanoacrylate may form a 
porous film which becomes invaded with blood. Subsequent clotting 
occurs within the pores of this film. 
Toxicity 
During this study it was not possible to determine the 
toxicity of cyanoacrylate in general surgical use. 
The key literature shows that toxicity investigations have 
been exhaustively carried out on cyanoacrylates for medical use. 
Histotoxicity effects of a wide range of cyanoacrylates on rats, guinea 
pigs, rabbits, cats, dogs, pigs, chimpanzees and human patients, as 
well as cultured fibroblasts have been assessed VINTERS et al. (1985). 
Studies with B-14C tagged methy-cyanoacrylate show that 
polymers formed in vivo are biodegradable CAMERON et al. (1965). 
Rats and guinea pigs were used as experimental animals by REYNOLDS 
et al. (1966). The data produced indicates that the metabolites 
produced from the degradation were eliminated through the normal 
excretory routes, none of the radioactive degradation products were 
ultimately retained in the tissues. In implantation experiments 
in guinea pigs the tagged polymer disappeared after 107 days. 
In rats the radioactive polymer had substantially disappeared within 
154 days. 
Further comparison experiments with several cyanoacrylates 
were made to determine the rates of disappearance. The data indicates 
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that the methyl homologue degrades at a faster rate, the n-butyl at 
the slowest. The polymers with branched alkoxy groups degrade at 
an intermediate rate (Fig. 40). 
The mechanism of polymer degradation has been demonstrated 
by LEONARD et al. (1966). Iershowed that cyanoacrylate polymer 
degrades in the presence of distilled water with the formation of 
formaldehyde. The process of degradation reaches an equilibrium 
state at which the amount of formaldehyde produced remains constant. 
This equilibrium value is reached slowly at pH7 at 25°C. In neutral 
boiling water the equilibrium can be reached at a faster rate (Fig. 41). 
The data of LEONARD indicates that the rate of aqueous 
degradation is considerably slower for the polymers of the higher 
alkyl esters. Methyl cyanoacrylate degrades much faster than others 
and the rate lessens for higher groups of the series. LEONARD's 
experiments show that the rates of degradation in vitro are analogous 
to the in vivo results. An important indication from this work is that 
as the homologous series is ascended the inflammatory responses in 
tissue are decreased. The butyl and higher homologues appear to be 
well tolerated by the tissues. 
The conclusion from the data available (WOODWARD et al. 
1965; MATSUMOTO et al. 1967; LEHMAN et al. 1966; MATSUMOTO et al. 
1967) is that the length of the alkyl chain determines the toxicity 
in the tissues with methyl being the most toxic and butyl being the 
most acceptable. 
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Colour Indicators 
The philosophy that colouring elements in biomaterials 
introduce a further toxicity factor has influenced colour additions 
to cyanoacrylate tissue adhesives. The advantage of including a 
pigment is to provide a means of identifying the adhesive when placed 
on the tissue surface in contrast to blood and body fluids. 
Standard cyanoacrylate bases are colourless and visually 
difficult to identify at the surgical site. A colour contrast would 
overcome this problem. Histoacryl (butyl 2 cyanoacrylate) has the 
individual feature of containing a contrast of intense blue dye. 
This colour is produced by 0.1% of 1-hydroxy-4 (-p-toluidino)- 
antranchinon: - 
4 
No reports of problems relating to this pigment addition 
have been reported in the literature. ROBERTS (1985) noted temporary 
pigment staining of the tissues five weeks after surgery. 
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novelly Fluorescent agents as additions to cyanoacrylate tissue 
adhesives have been investigated in this study. The use of these 
indicators requires instrumentation to irradiate the cyanoacrylate. 
Sterility 
Considerable controversy exists concerning the sterility and 
sterilization of cyanoacrylates for medical use. FASSETT (1961) in 
toxicity studies of Methyl 2-cyanoacrylate concluded that his in vitro 
investigation proved the ester to be self-sterilizing. He placed drops 
of Methyl 2-cyanoacrylate containing Escherichia coli and Staphylococcus 
aureus onto dishes containing nutrient agar and incubated at 37°C for 
24 hours. No bacterial growth was seen on the plates. AWE et al. (1963) 
investigated Methyl 2-cyanoacrylate. From this bacteriological study 
they indicate cyanoacrylate to be both bacteriostatic and bacteriocidal 
in vitro. Mild inflammatory reaction, but no tissue necrosis was seen 
on histological section of dog heart and aorta. The mild degree of 
inflammatory reaction seen in the histological sections compared 
favourably, with the cellular response evoked by accepted surgical 
suture. Again they conclude from sterility testing that cyano- 
acrylate is self-sterilizing and that only the containers need to be 
sterilized. 
LEHMAN et al. (1966) reported the effects of straight chain 
-- Eschc'ichia sraPhyoaocus 
alkyl 2-cyanoacrylates upon the growth of . coli and 
ý. aureus in vitro. 
No growth resulted; it was considered from this that cyanoacrylates 
were bacteriotoxic and therefore self-sterilizing. JANDINSKI & SONIS 
(1971) demonstrated the destruction of growing colonies of bacteria 
in vitro. They used a method of zoned bulls eye pattern cultured 
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nutrient agar to measure the degree of inhibition on four bacteria. 
Isobutyl cyanoacrylate was used in this study. It was observed that 
SFQp ylococu. Microcows te/-a9enu$ V, ' 'ans, neisseria 
from the four bacteria (fi. aureus, -9af-¬1 yeh Streptococcuy, . catarrhalis) 
S. aureus was the only one destroyed completely by the application of 
the cyanoacrylate. The other bacteria showed zones of inhibition on a 
decreasing scale from the centre to the outer zone. 
The opinion that cyanoacrylates are self-sterilizing by their 
chemical formulation is supported by CHARNLEY (1970), HULLINGER (1962), 
ROBERTS (1966), ROBERTS (1967) from experience with monimers of methyl- 
methacrylate in bone cement used in orthopaedic surgery. 
KAPLAN & BORCHARDT (1966) investigating the antibacterial 
properties of Methyl 2-cyanoacrylate in a series of surgical experiments 
on guinea pigs found bacteria present from cultured fluid from wound 
sites bonded with cyanoacrylate. MATSUMOTO (1971) also found in 
bacteriological studies of wound sites bonded with cyanoacrylate 
bacteria was present, in drained fluid. He indicates that these 
esters may not be bacteriostatic and bacteriocidal as others conclude 
conclude. Sterilization is recommended for container materials and 
methods of application. 
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Sterilization 
The problem of sterilizing cyanoacrylates is that the cure 
mechanism is activated and the material polymerised by the use of 
non-standard sterilization protocols. Autoclave systems are not 
used since the water vapour present rapidly promotes polymer- 
isation. 
Ethylene oxide reacts with cyanoacrylate, destabilising 
the adhesive. A further problem is that of gas absorption and 
degassing procedures. 
Gamma irradiation by Cobalt 60 is a method claimed by 
manufacturers of cyanoacrylate tissue adhesive. The standard 
irradiation dose and time cycle is 2.5 Mrad (25kGY*) for 6-7 
hours. Exposure time is dependent on the mass of the product 
irradiated and the density of the container used. Difficulties arise 
with the irradiation of cyanoacrylates. Viscosity levels of 120 cP 
and above polymerise at the standard dose rate of 25 kGY. Stepped 
down dose rates of 15.0 kGY and 12.5 kGY produce changes in viscos- 
ity. The cyanoacrylate is sterile but too thick to apply in 
droplet form. To overcome this problem manufacturers have used 7.5 kGY 
on 3 cl low viscosity cyanoacrylate. DIXON (1988) indicates that 
this level of irradiation may not be sufficient to destroy certain 
bacteria. 
*lrad 
= 0.01, kGY (Gray units now replace Rads) 
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Dry heat is a well-established means of sterilization in 
medicine. Cyanoacrylates can be sterilized under correct conditions 
by dry heat. A temperature of 160°C for 1 hour is required and is 
theestandard protocol in UK sterile supply units. The cyano- 
acrylate must be placed in a glass container free from air and 
moisture and the neck of the container sealed before being subjected 
to the dry heat cycle. This form of sterilization for commercial 
production requires specialised equipment to load and seal the sterile 
cyanoacrylate tissue adhesive in containers for storage and use. 
Limited amounts of cyanoacrylate tissue adhesive for immediate clinical 
use can be sterilized with a hospital facility. 
A new experimental method of sterilizing cyanoacrylates 
is being developed. Photosensitised cyanoacrylate subjected to a 
laser light beam has been found in initial experiments to destroy 
bacteria in the material, with little alteration to the cure 
mechanisms. Protoporphyrin IX dimethylester mixed with cyanoacrylate 
is exposed for fixed periods of time to a laser light source. 
The photodynamic action of the Protoporphyrin on the 
biological system is mainly due to the transfer of energy from the 
Protoporphyrin molecule to the oxygen present in bacterial cells. 
This transfer of energy upsets the electron structure of the oxygen 
atom transforming then momentarily into highly reactive singlet 
oxygen that attacks everything surrounding it. The generation of 
singlet oxygen (102) is believed to be the cytotoxic agent which 
destroys the bacteria present. Work with this method of sterilization 
is continuing. 
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An important consideration in sterilization methods for 
cyanoacrylates is the selection of container and materials used in 
their construction. High density polyethylene is the most satis- 
factory material. A wall thickness of 0.8 mm is required for 
stabilization purposes during sterilization. Wall thickness of 
less than 0.8 mm has been found to split during irradiation. 
Glass is a satisfactory material for containers, in particular 
when dry heat methods are used. Before cyanoacrylate tissue 
adhesive is dispensed into a container the container itself must 
be clean and pre-sterilized. 
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MATERIALS AND METHODS 
The cyanoacrylate tissue adhesive used in this study was 
n-butyl 413* 20cP supplied unsterile in 20 gram size non pigmented 
high density polyethylene containers with a wall thickness of 0.8 mm. 
The polymerising time is within 10 seconds and an operating temperature 
-60°C to +80°C. 
Fluorescent agents 
Various fluorescent agents were recommended as possible 
indicators for addition to n-butyl 413 cyanoacrylate. Thirteen agents 
were examined for (a) solubility, (b). fluorescence, (c) stability. 
The fluorescent agents examined were: 
1. Anthracene 
2. Acenaphthene 
3. Salicylaldehyde oxime 
4. Phenanthrene 
5. Guaiacyl crabonate 
6. Benzylidene acetophenone 
7. Benzoin -oxime 
8. Dibromofluorescein 
9.8-Hydroxyquinoline 
10. Methyl p-hydroxybenzoate 
11. Sodium fluorescein 
12. Pylam LI-990** 
13. Natmer LI 1158*** 
The agents were added to n-butyl 413 20 cP cyanoacrylate in 2% concen- 
tration. The cyanoacrylate-fluorescent formulation in 0.01 gram drop 
size were placed on glass dishes. Each drop was examined under ultra- 
violet (uv) light at 254 nm and 365 nm. All the fluorescent agents 
were examined separately in 2 gram amounts placed on glass dishes. 
The same uv light concentrations were used.. 
Sterilization procedures 
Sterilization of n-butyl 413 cyanoacrylate used for all 
clinical tissue bonding in this study has been the dry heat method. 
A 50 ml pyrex glass conical beaker was used to contain the cyano- 
acrylate during sterilization. The 50 ml glass beakers used were first 
*n-butyl 413 Loctite *44Pröprietary names Loctite (Ireland) R&D 
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steam cleaned, hot air dried and packed in standard sterilizer bags. 
Sterilization of the beaker is carried out by the hospital central 
sterile supply department at the standard dry heat cycle of 160°C 
for 1 hour. The polyethylene containers, 20 ml size used to fit the 
Medical Bondmatic II applicator, were steam cleaned, hot air dried and 
packed in standard sterilizer bags. Gamma irradiation sterilization was 
used at the standard irradiation dose of 25 kGY for 7 hours. This pro- 
cedure was carried out by Isotron plc, Bradford. 
To prepare the n-butyl 413 cyanoacrylate tissue adhesive for 
use the 50 ml pyrex glass-beaker is removed from the sterile pack under 
clean room conditions and 20 ml of n-butyl 413 20 cP cyanoacrylate 
dispensed into the glass beaker. The beaker is sealed bya film of medical 
grade silicone adhesive* A, placed on the rim of the beaker, then covered 
with tin foil . 007 inch thickness. The tin foil is adapted round the neck 
of the beaker to form a seal, with the silicone adhesive. The glass 
beaker is placed in a Gallenkamp OVH-400 oven/sterilizer at a constant 
temperature of 160°C for 1 hour. In predicted operations all sterilization 
procedures are completed in the morning ready for an afternoon operating 
theatre list. If time factors allow the oven may be switched off following 
the 1 hour cycle and the beaker and contents cooled to room temperature. 
The sterilized cyanoacrylate is transported to the operating 
theatre and under sterile conditions the beaker opened and the cyanoacrylate 
dispensed into the pre-sterilized polyethylene container. The tubing 
and setting up of the Medical Bondmatic II is completed ready for use. 
*Dow Corning medical grade adhesive for implant use 
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Application Methods 
The near instant setting time of cyanoacrylate adhesive on 
contact with tissues requires that its method of application be precise 
and confined to the location intended by the surgeon. 
A number of methods of application have been used with 
varying success. The difficulty of application in clinical use has 
been a deterrent to more general use in surgery. MATSUMOTO et al. 
(1967), MATSUMOTO et al. (1972) used a small spray bottle to apply 
the adhesive over a surgical site. The adjacent area was protected 
by polyethylene sheet. This method has the disadvantage of lack of 
control, and confinement of of the adhesive to the surgical site. 
Spray application has clinical indications in acute hemorrhage 
control in large internal organs (MATSUMOTO 1967 and KIRKEGUARD et 
al. 1977). 
A teflon roller constructed of 12-16 spike like Dro, iections 
per square centimetre was devised by GOTTLOB et al. (1980). The 
roller is passed through the cyanoacrylate so that each projection 
is charged with a drop of adhesive. Passed across the tissue or graft, 
the charged projections provide a grid pattern on the surface. 
The roller can be modified to have grooves in place of 
projections. This design provides a strip pattern on the tissue or 
graft. GOTTLOB et al. describe the advantage of this technique as 
tissue ingrowth and union achieved by the pattern effect in constrast 
to a continuous layer. 
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Cyanoacrylate (HISTOACRYL) has been applied extensively 
in surgery by means of a polythene vial. The nozzle of the vial 
is designed to fit an extension tube of varied length and bore size. 
The tip of the vial nozzle is cut and the adhesive expressed by 
squeezing the vial. 
Differing patterns of application are achieved by means 
of the extension tube selected. 
This application method is an advantage in emergency 
situations such as military surgery. Storage and immediate avail- 
ability are further considerations. 
The disadvantages are lack of application control and 
handling problems. When squeezing the vial, adhesive often comes 
in contact with the surgeon's gloves. Even with the extension tube 
attached access to certain surgical sites is difficult. 
Precision Applicator: Medical Bondmatic I 
The deficiency in current clinical methods of cyanoacrylate 
application emphasizes the need to design and develop a precision 
system for use in the operating theatre BAKER(1983); SHARPE(1985). 
Loctite UK had an established industrial dispenser. * This was at 
first modified and following clinical trials redesigned to specific 
medical requirements and designated Medical Bondmatic I. ** 
*Applicator Model S. A. U. 
**Medical Bondmatic pressure-time unit Mk. I constructed by Loctite UK. 
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The Medical Bondmatic I pressure time unit was constructed in 
4 mm thick stainless steel. The size of the unit is 19 cm x 25 cm 
x 25 cm and weighs 4 kg. 
The unit has been designed to dispense metered amounts 
of cyanoacrylate in a viscosity range of 10 cP to 10,000 cP. 
It-,. will maintain a consistent precision repeatability of drop size 
from 0.01 gram through to a continuous flow. 
The Medical Bondmatic I is an electro-pneumatic unit (Fig. 42). 
The unit requires a mains 240V 50Hz mains supply and an air supply of 
60 p. s. i. from an air bottle or alternatively a "Sparklets" CO2 
bulb can be used. The cyanoacrylate tissue adhesive is forced 
under pressure from a reservoir to a normally closed pinch valve 
located on the side panel. 
The pinch valve is opened by an actuation switch foot pedal 
and closed when the timer has complted its cycle. The precise amount 
of adhesive dispensed is dependent upon the air pressure applied and 
the length of time the pinch valve remains open. These two adjustments 
are made via the front panel instrumentation (Fig. 43). The unit 
fits on a standard operating theatre trolley. 
Controls 
The unit functions in two modes to allow the surgeon 
options of use. The dispense mode switch will activate the 
functions of continuous flow when the unit will run for the dur- 
ation of the input signal supplied. In the time mode the unit will 
run for the duration of internal timer only. 
P)? 
Figure 42 Assembled Medical Bondmatic I 
pressure-time unit; ready for use. 
(a) Switch foot pedal 
(c) pinch valve 
(d) air supply 
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To generate flow in the system the unit is primed via 
thedispense mode switch held in the "prime" position. The switch 
will return to time control automatically when released. The 
time control unit is set at 0-2 seconds and operative when in the 
timed position mode. 
Reservoir pressure is adjusted by means of the regulator. 
Pressure of the reservoir is indicated by the front gauge. 
Tubing system 
The tubing system for the Medical Bondmatic I, together 
with the lurelock connectors, are constructed of Polytetrafluorethane 
(PTFE). This material is non-reactive and does not form bonds with 
the cyanoacrylate and allows free flow in the tube (Fig. 44). A practical 
operating length of tube taken from the unit has been established as 
1 metre. Extension or reduction of this length is possible by means 
of lurelock connectors. The PTFE tube system, together with pinch 
valve section and applicator nozzle (Teflon) are packed sterile 
ready for assembly in the operating theatre (Fig. 45). A hand- 
piece constructed of stainless steel is also packed sterile to mate with 
the tube assembly system. 
Operation 
In the operating theatre a 20 gram container of n-butyl 413 
is placed in the pressure reservoir of the Medical Bondmatic I. The 
sterile tubing system is assembled with one end of the tube placed in 
the bottle. The assembly is completed through the pinch valve and 
located via the lurelock connectors to the 1 metre operating tube, 
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MEDICAL BONDMATIC I 
PRESSURE-TIME UNIT 
Schematic Of Tubing System 
Figure 44 
Pressure Guard PTFE Tubing 
Reservoir 
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Figure 45 
Steril,, park: containing tube system and nozzle 
ready for use in operating theatre. 
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which An turn is connected by a slide fit through the hand 
piece (Figs. 46 & 47). 
A selection of nozzle sizes (Fig. 48) are available. 
For the majority of plastic surgery operations 22 SWG (b) has been 
used. In ENT surgery 17 SWG (a) with the extra length for access 
has found favour. Other nozzle sizes are used as the surgeon 
requires. The nozzle selected fits over the lurelock connector 
completing the assembly. 
The Medical Bondmatic I is connected to the mains electricity 
supply, pressure reservoir filled by the air supply and adhesive 
flow established by priming. When positioned alongside the operating 
table ready for use (Figs. 49 & 50) the surgeon selects the 
function mode (time or flow) by means of the footswitch. A special 
stainless steel trolley has been designed to provide a working top and 
air bottle stand for the Medical Bondmatic Unit. 
Medical Bondmatic II 
Clinical experience over a four year period with the Medical 
Bondmatic I has served to identify points for improvement, resulting in 
the design of the Medical Bondmatic II (Figs. 51 & 52). 
The improved unit 19 cm x 25. cm x 43 cm weight 8 kg, has handles on 
the side panels of the stainless steel case for ease of transportation. 
Improved features incorporated are: - 
1' f 
Figure 46 Handpiece-nozzle lure lock assembly 
Figure 47 Assembled handpiece-nozzle ready for use 
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Figure 49 Medical Bondmatic I pressure line unit 
precision application of Cyanoacrylate: 
note contrast of conventional ligation. 
Figure 50 Cyanoacrylate tissue adhesive applied 
to margins of skin graft with 25 SWG nozzlE 
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Figure 51 
Medical Bondmatic II with peristaltic pump and 
fibre optic light option. 
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1. A peristaltic pump to replace the pressure reservoir. 
This provides trouble-free pumping of the tissue adhesive from 
the container direct to the handpiece applicator. 
2. A simplified system for tubing the unit which reduces the 
time of assembly in the operating theatre. 
3. A UV light unit (365 nm) is built in as an option for using 
fluorescent cyanoacrylate as it is dispensed. The UV light is 
trnsmitted down a flexible fibre optic light cable to colocate with 
the handpiece applicator (Fig. 53). 
Controls 
The Medical Bondmatic II has the two function modes as in 
the Mark I. The speed of the peristaltic pump relates to the amount 
of cyanoacrylate dispensed and is controlled from the front panel dial. 
The time switch on the unit is set at 0-2 seconds, the circuit operates 
when the mode switch is in the timed position. 
To use the UV light option, the mode switch at 'ON' provides 
for continued UV light through the fibre optic cable. If this mode 
is not required the switch in the 'OFF' position allows only the cyano- 
acrylate adhesive to be dispensed. 
In the automatic mode the UV light comes on just before the 
cyanoacrylate adhesive starts to dispense and remains on following the 
dispense cycle for a few seconds. This delay can be further adjusted 
by the UV delay control. 
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Figure 53 
Fibre optic light colocated with the handpiece applicator 
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The cyanoacrylate tissue adhesive container is positioned 
externally on the Medical Bondmatic II. A location clamp allows the 
20 gram container to be seated easily below the peristaltic pump which 
is positioned on top of the unit. 
Tubing system 
The tubing system for the Medical Bondmatic II is packed 
sterile as for the Mark I model. The system comprises a PTFE 
connector and tube extension to fit into the cyanoacrylate container. 
Medical grade silicone tube 1 metre long with lurelock connector. 
A PTFE tube sleeve for the handpiece with lurelock fitting and 
applicator nozzle (Fig. 54). 
Operation 
In the operating theatre a 20 gram container of n-butyl 413 is 
placed into the location clip. The silicone tube is connected via the 
lurelock fitting and inserted into the cyanoacrylate container. 
The silicone tube is threaded through the peristaltic pump 
head. The free end of the silicone tube is connected to the PTFE 
tube which is sleeved through the pre-sterilized anodized aluminium 
handpiece. Finally the nozzle is fitted. 
The UV light probe is connected if required by a push-fit 
into the handpiece assembly and the angle adjusted. 
The fibre optic cable is connected into the unit front 
panel. When connected to the mains electricity supply the Medical 
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Bondmatic II is ready for use. The surgeon uses the footswitch to 
operate the unit. 
It has been found that the tubed unit allows a theatre 
list to be completed without dismantling the system beyond the hand- 
piece and nozzle. The tube connectors and nozzle are graded as 
disposable while the handpiece is sterilized for each case. One 
container of cyanoacrylate adhesive is sufficient for an average 
skin graft case. 
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Survey 
A national survey was completed on the use of cyanoacrylate 
adhesive in surgery. Two groups of surgeons, Plastic Surgeons and 
Oral and Maxillo-facial Surgeons, were chosen for the survey. These 
two surgical disciplines were known to use cyanoacrylate as tissue 
adhesives. Both groups are concerned with reconstructive surgery and 
collaborate in the treatment of patients. 
Permission was obtained from the President of the British 
Association of Plastic Surgeons and the President of the British 
Association of Oral and Maxillo-facial Surgeons to conduct the survey. 
The Secretaries of both Associations at the Royal College of Surgeons 
of England provided current lists of their members. To ensure a good 
return from the survey and minimise the cost of postage, only United 
Kingdom members were circulated. 
Each surgeon's name in the survey list was allocated a 
reference number for future individual contact if required. The mail- 
out envelope contained a letter to each Surgeon (Figs. 55 & 56). 
a questionnaire (Fig. 57) - this was the same for both groups of 
surgeons - and a pre-paid return envelope to the School of Biomedical 
Sciences at the University of Bradford. 
The questionnaire contained eight questions to be answered 
by box-marking together with any relevant comments regarding the use 
of cyanoacrylate adhesives. 
Plastic Surgery and Burns Research Unit 
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Dear Sir 
Professor 
TERRY G BAKER DSc MRC Path FRSE 
Plastic Surgery and Burns Research Unit 
Director 
DAVID T SHARPE OBE MA FRCS 
Bradford West Yorkshire BD7 1DP 
telex 51309 UNIBFD G 
0 0274 733466 ext215/6106/6162 
I am indebted to the British Association of Plastic Surgeons 
for permissionto send out this questionnaire. I am 
completing a doctoral research programme into the use of 
adhesives in surgery with particular reference to a 
specifically formulated cyanoacrylate base as a tissue 
adhesive. My research has also been concerned with the 
design and development of a precision method of delivery and 
application system for use in the operating theatre or 
clinic. 
I currently hold an appointment as a Clinical Scientist in 
the Department of Plastic and Maxillo-facial surgery at 
St Luke's Hospital, Bradford, where most of the clinical 
trials are being completed. The results so far are most 
encouraging. 
I would greatly appreciate a few moments of your valuable 
time in providing me with the information I require to 
establish the present pattern and future possible use of 
adhesives in plastic and reconstructive surgery and if you 
feel able to comment further,, your remarks would be of 
particular help to me. I enclose a pre-paid envelope for 
return of the questionnaire. 
If you would like to know the final details of the 
formulated adhesive and delivery system, I would be pleased 
to send this to you at the completion of the research 
programme. 
I do hope that you will be able to help me with my enquiries 
and I thank you in anticipation. 
Yours faithfully 
ALAN C ROBERTS 
MBE, TD, DL, MPhil, CBiol, FIBiol 
University of ýP 
ostgraduate and Undergraduate 
Schools of Biomedical Sciences 
Figure 55 
Plastic Surgery and Burns Research Unit 
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Dear Sir 
Professor 
TERRY G BAKER DSc MRC Path FRSE 
Plastic Surgery and Burns Research Unit 
Director 
DAVID T SHARPE OBE MA FRCS 
Bradford West Yorkshire BD? 1 DP 
telex 51309 UNIBFD G 
V 0274 733466 ext 215/6106/6162 
I am indebted to the British Association of Oral and 
Maxillo-facial Surgeons for permission to send out this 
questionnaire. I am completing a doctoral research 
programme into the use of adhesives in surgery with 
particular reference to a specially formulated cyanoacrylate 
base as a tissue adhesive. My research has also been 
concerned with the design and development of a precision 
method of delivery and application system for use in the 
operating theatre or clinic. 
I currently hold an appointment as a clinical Scientist in 
the Department of Plastic and Maxillo-facial Surgery at St 
Luke's Hospital, Bradford, where most of the clinical trials 
are being completed. The results so far are most 
encouraging. 
I would greatly appreciate a few moments of your valuable 
time in providing me with the information I require to 
establish the present pattern and future possible use of 
adhesives in oral and maxillo-facial surgery and if you feel 
able to comment further, your remarks would be of particular help to me. I enclose a pre-paid envelope for return of the 
questionnaire. 
If you would like to know the final details of the 
formulated adhesive and delivery system, I would be pleased 
to send this to you at the completion of the research 
programme. 
I do hope that you will be able to help me with my enquiries 
and I thank you in anticipation. 
Yours faithfully 
ALAN C ROBERTS 
MBE, TD, DL, MPhil, CBiol, FIBiol 
University of BJRADFQRD 
Postgraduate and Undergraduate 
Schools of Biomedical Sciences 
Figure 56 
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Form No 
UNIVERSTIY OF BRADFORD 
PLASTIC SURGERY AND BURNS RESEARCH UNIT 
SURGICAL USE OF CYANOACRYLATE ADHESIVE- 
-QUESTIONNAIRE 
Please tick the boxes to indicate your answer, you may tick 
more than one choice for questions 3 and 4 if necessary 
1 Do you use cyanoacsylate Yes II A 
adt re ? (If Yid, please No F --j B 
proceed to question 7) 
2 How often do you use Less than once a year II C 
such adbesives ? 1-12 times ayear C] D 
13-52 fimes ayear QE 
53 armcae tines 
ayear II F 
3 Which adhesves have Histcaacyl IG 
you used ?" Henkel =H 
Name umbi [] I 
Odems (please specify) IJ 
4 What have you used it for ? Skin graft fixation 0K 
Wand dose ue 0L 
Fbiliou of dresskgs 
crdeAas [] M 
Odxm . se II N 
5 Have you had problems Yes II O 
apptying the adhessive ? No II P 
6 Would aprecision ýPhý' Yes 
help? N o 
ýR 
7 If a superior adhesive were Yes =]S 
available would you consider No __ 
T 
its use? 
8 Would you be interested in Yes DU 
hearing the results of this No =V 
survey ? 
9 Have you any other comments to make on the surgical 
use of cyanoacrylate adhesives ? 
Thank you for taking the time to fill in this questionnaire 
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The questions asked were constructed to obtain information 
for the future development of cyanoacrylates as tissue adhesives, together 
with precision methods of application. 
The number of questionnaires sent out totalled 1,034, comprising 
Plastic Surgeons 289, Oral and Maxillo-facial Surgeons 745. No time- 
limit was set for the return of the questionnaires. 
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Review of tissue adhesive patients 
Among the patients who sustained severe burns in the Bradford 
football stadium fire twenty in all had grafts attached with n-butyl 
cyanoacrylate tissue adhesive. 
A review of this group of patients was held three years follow- 
ing initial surgery. The twenty patients were asked to attend. Each 
patient was informed that the review concerned the use of tissue 
adhesive at the time of their surgery. 
Of the twenty patients sent for 15 attended. 2 did not wish 
to attend, reporting that they were well and active. 1 failed to 
attend and 2 patients had recently died from unrelated causes. 
The fifteen patients were examined in Mr. David Sharpe's 
plastic surgery out-patients clinic at St. Luke's Hospital, Bradford. 
The observations were recorded on purpose-designed forms (Figs. 58 & 59). 
Review observations were: GRAFT SURFACE TEXTURE - satisfactory = 80%; 
fair = 15%; poor = 5% GRAFT COLOUR - red = 13; hyper-pigmented = 80%; 
normal = 7% GRAFT CENTRE - flat = 0% GRAFT EDGE - flat = 95%; 
raised = 5% GRAFT ELASTICITY - normal = 87%; less = 13% 
INSTABILITY'- none = 0% CYST FORMATION - none = 0% CONTRACTURE - none 
= 87%; moderate = 13%. 
All the patients examined were cheerful and reported no 
significant clinical problems. All were pleased to be seen, and to 
meet their surgeon again. All expressed an interest in the fact that 
a non-conventional method had been used in support of their surgery. 
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PLASTIC SURGERY AND BURNS RESEARCH UNIT 
TISSUE ADHESIVE REVIEW CLINIC 
PATIENTS NAME OBSERVER 
LOCATION DATE 
Graft Surface Texture 1. Normal 2. Satisfactory 3. Fair 4. Poor 
Graft Colour 1. Normal 2. Red 3. Hyper-Pigmented 4. Hypo-Pigmented 
Graft Centre 1. Flat 2. Raised 3. Depressed 
Graft Edge 1. Flat 2. Raised 3. Depressed 
Graft Elasticity 1. Normal 2. Less 3. More 
Graft Instability 1. None 2. Some 3. Severe 
Cyst Formation 1. None 2. Few 3. Many 
Contracture 1. None 2. Moderate 3. Severe 
COMMENTS : 
Figure 58 
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PLASTIC SURGERY AND BURNS RESEARCH UNIT 
TISSUE ADHESIVE REVIEW CLINIC 
PATIENTS NAME 
Figure 59 
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Case Reports 
Case 1 (Fig. 60). 
(12.5.85) Patient: male aged 65 years. Involved in 
Bradford football stadium fire. Sustained burns to hands, buttocks and 
back of legs. Total area of burns 19Y2%. Operation (14.5.85). 
Excision and partial shaving of forehead. Graft left exposed, 
tangential excision, left hand up to MEP joint. Tourniquet 
excision, right hand dorsum of hand and proximal and middle phalange 
down to paratenon. Tangential excision portion of wrist. Grafts 
attached with n-butyl cyanoacrylate. At first dressing (21.5.85) 
left hand 30% take of graft. Further stored skin applied. Right 
hand 60% take of graft. Forehead 90% take of graft. At second 
dressing (25.5.85) scalp mostly taken, left hand, second graft not 
taken - removed. Both calves redressed, donor site, right hand 
redressed. Home (27.7.85). Burns review clinic (31.10.85). Left 
hand functioning extremely well. Graft settled, no problem of 
function. Right hand has considerable disability and extension 
deformity. Unlikely to improve in view of underlying pathology of 
the tendon. Continued physiotherapy. Burns review clinic (23.1.86). 
Continues to make good progress with both hands, continue to review. 
Special review clinic (14.7.88). Good progress continues. Patient 
cheerful, areas of graft where tissue adhesive used observed and 
recorded, no problems. 
1 77 
I : 5: ý5 
14: 5: 85 
23: 1: 85 
CASE I 
Figure 60 
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Case 2 (Fig. 61) 
(11.5.85) Female aged 82 years involved in Bradford 
football stadium fire, sustained burns to top of head, dorsum of 
right hand, cheek and both calves. Total area of burn 3%. Operation 
(14.5.85). Joint division of scalp and burn of left leg to allow 
mobility. Arm tourniquet, shaving of dorsum of right hand plus proximal 
compartments. Meshed skin graft applied from forearm. Operation 
(10.6.88). Split skin graft from right upper arm applied to granulating 
area, dorsum of right hand. Operation (20.6.85). Defect 7" x 4" on 
scalp grafted with skin from left arm. Graft attached with n-butyl 
cyanoacrylate tissue adhesive. Home (28.6.88). Burns Clinic (2.7.85). 
Right hand healed. Scalp crusted plus a few raw areas posteriorly. Leg, 
small area to heal 2" x 1". Donor sites (R) and (L) not yet healed. 
Left leg nearly healed, left arm donor site virtually healed. Right arm 
donor site overgranulated. Burns Clinic (23.7.85). Leg healed, both arms 
healed. Dressing continued. Wig prescribed. Burns Clinic (30.7.88). 
Donor sites healed. Burns Clinic (31.10.85). Patient looks very well. 
Scalp healed well, reports no problems, no psychological, upsets. 
Continue to review. Special Review Clinic (14.7.88). Patient very 
well, cheerful, continues to make progress. Graft area of scalp where 
tissue adhesive used observed and recorded, no problems. 
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Case 3 (Fig. 62) 
(12.5.85) Patient male aged 66 years. Admitted with burns 
of backs of both hands, both legs and backs of ears. Total area of 
burn 4%. Involved in fire at Bradford City football ground. Operation; 
left hand, test shave dorsum of index finger, split skin graft to web 
space. Shave and graft radial side of dorsum, graft attached with n-butyl 
cyanoacrylate tissue adhesive. Donor, left forearm, volar surface 
(19.5.85). Dressing (1.6.85). Swelling right ankle has settled. 
Flamazine bag right hand (10.6.85). Needs graft to right hand and 
right leg. Operation (14.6.85). Rub and split skin graft to both 
calves, areas 5x4 cm (left, 7x5 cm (right) grafts attached with n- 
butyl cyanoacrylate tissue adhesive. Split skin graft from left thigh, 
surplus skin stored (10.6.85). Right leg, graft good, left leg, graft 
still alittle mobile. (25.6.85) Grafts have taken, mobilise. Home 
(27.6.85). Burns Clinic (2.7.85). All healed, double tubigrip, con- 
tinued review. Burns Clinic (10.10.85). Good improvement. Well 
healed, continue review. Special Review Clinic (14.7.88). Has made 
continued progress. Graft areas where tissue adhesive used observed 
and recorded, no problems. 
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Case 4 (Fig. 63) 
(11.5.85) Patient, female aged 67 years. Involved in 
Bradford football stadium fire. Sustained burns to face, both hands, 
back, shoulders and legs. Total area of burns 18%. Operation: 
Tourniquet, excision, full thickness burn dorsum left hand and finger; 
tourniquet removed and haemastasis achieved. Sheet graft applied. 
Right hand, excision full thickness burn dorsum right hand and fingers 
under tourniquet. Meshed. Split skin graft attached with n-butyl 
cyanoacrylate tissue adhesive (21.5.85). First dressing left hand 5% 
take of graft. Right hand 10% take of graft, both infected. Scalp 10% 
of graft taken (25.5.85). Right hand 10% take of graft, exposure of 
tendons but not necrotic. Left hand exposure of tendons but not 
necrotic. (7.8.85) Operation: grafting of granulating burns of both 
hands, left arms, forehead and back and both thighs. Head 3Y2 crusted 
burns desloughed and grafted. Right hand patchy granulations of dorsum 
of hand and fingers. Left hand, most of the hand and all fingers 
granulated. (28.6.85) Operation: granulation on back grafted, graft 
attached with n-butyl cyanoacrylate tissue adhesive. Home (27.5.85). 
Burns Clinic (31.10.85) hands improving, physiotherapy continued. Although 
short of skin on both extensor surfaces of hand, surgery is not indicated 
at present time. Scalp and back dressing continued. Burns Clinic (30.1.86) 
area of bone on skull has separated, epithelization has taken place. 
Both hands functioning well. Back area good progress, continue to 
rview. Special review clinic (14.7.88). Good progress. Patient 
very cheerful, pleased with results, no problems. 
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Case 5 (Fig. 64) 
(12.5.88) Patient male aged 27 years. Admitted via 
Bradford Royal Infirmary casualty department. Involved in the 
Bradford football stadium fire. Sustained burns to both hands and 
back of head. Total area of burn 2%. Operation: (13.5.85). 
Tangential excision and graft to right hand. Graft attached with n- 
butyl cyanoacrylate tissue adhesive. Dressing (18.5.88). Home 
(27.5.85). Burns Clinic (4.6.85). Well healed full movement. Donor 
area, thigh healed, review three months. (12.9.85) Excellent 
result for right hand, further review in twelve months. Special review 
clinic (14.7.88). Excellent result on hand. Patient very pleased 
with this, reports an awkward scar of left leg which has been causing 
problems, keen sportsman, the skin keeps breaking down. Suitable for 
tisue expansion on both sides to stretch this out (2 x 500 cc rectangular 
or crescentic expanders) name on waiting list, no other problems. 
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(A) One month after burn injury, initially treated conservatively 
with dressings. This failed to heal. Now has granulating 
wound. Skin graft applied and attached with n-butyl 
cyanoacrylate tissue adhesive. 
(B) Result 3 years later. 
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RESULTS AND DISCUSSION 
Prosthetic Adhesive 
The classification of prosthetic adhesive based on the chemical 
characteristics of polarity set out in Table 11 provide the basis for 
grouping the type of prosthetic adhesive formulation most suitable for 
the prosthetic material selected. 
In clinical practice the problem often occurs of patients not 
being able to attach a facial or body prosthesis due to non-adherence of 
the adhesive used. Patients are referred to this Centre for an opinion 
concerning non-adhesion of a device vital to the treatment programme. The 
solution to most of these problems is that of adhesive selection in 
relation to the material requiring attachment to the skin. By understanding 
the polarity groupings more effective adhesives can be selected to 
provide adherence and function. 
4-%A MAP LIES 
The work of SCHMIDT (1948) concerning the mechanism and factors 
of adhesion is of particular relevance to the attachment and retention 
of facial prostheses and devices. The need is to concentrate energy at 
the limited surface area interfaces of prosthesis and adhesive together 
with that of the skin and adhesive. 
The formulation of prosthetic adhesives compatible with the 
low polarity prosthetic materials set out in Table 12 provide adherence 
and retain the viscoelastic characteristic for this group of materials 
which are being increasingly used in the clinical area. 
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An essential property of a prosthetic adhesive has been 
found to be adhesion on contact with the skin. STEFAN 
(1874)deter- 
mined the importance of the tackiness factor in adhesion and the 
effect of time of maximum adherence. The STEFAN tackiness factor is 
achieved with the viscous hydrocarbon group of adhesives. The high 
degree of adhesion in this group has been found most satisfactory in 
the attachment of Silicone Elastomer prostheses to the skin. Tackiness 
and adhesion even in the prescence of increased metabolic exudates make 
this group of adhesives the most acceptable to our patients. 
The Plastic Surgery Department of St. Luke's Hospital, Bradford 
has developed the use of nipple-aerola prostheses following breast recon- 
struction. The technique places particular reliance on the adhesive used. 
The selection and use of a low polarity viscous hydrocarbon contact adhesive 
has provided effective adhesion. Patients report complete confidence in 
the prosthetic restoration based on ease of application and adhesion even 
during prolonged exposure to sun and sea water in tropical conditions. 
The medium polarity group of adhesives was used in the early 
development of prosthetic materials. This group has been found to oxidise 
rapidly with subsequent loss of adherence. The medium polarity group 
is not effective in the adhesion of silicone elastomer and has not been 
used in this study. 
High polarity group adhesives find limited use in facial pros- 
thetics, being least effective for long-term adhesion and attachment. 
All groups find application for temporary dressings and tapes. 
Commercial manufacturers use balanced formulations to the specialized 
application of their products. 
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Tissue Adhesives 
Three cyanoacrylates have been examined as tissue adhesives 
in this study; methyl, ethyl and n-butyl. The larger size molecule 
ester n-butyl cyanoacrylate 413 120 cP with a cure speed of 10 seconds 
has been satisfactory for our clinical requirements. The n-butyl 413 
cyanoacrylate is more tolerated by the tissues than the other lower 
homologs. The n-butyl degrades at a slower rate than both methyl and 
ethyl cyanoacrylate. Both are not well tolerated by the tissues. The 
tissues more easily metabolize the lower concentration of degradation 
of the , n-butyl 413. 
The difficulty of selecting a method of sterilization for 
cyanoacrylate has been examined. Dry heat has been the method used in 
clinical applications. The experimental use of Protoporphyrin IX 
dimethylester as a sterilization agent has been used. This method com- 
bines both sterilization and fluorescence. 
The precision applicator designed and developed for application 
of the cyanoacrylate in the operating theatre enables fast cure times to 
be exploited and defined amonunts dispensed. A peristaltic pump provides 
the pressure required to dispense the cyanoacrylate. The system combines 
a UV light option for location of cyanoacrylate tissue adhesive formulated 
with a fluorescent agent. The fluorescent agents investigated in this 
study have no history of medical use with tissue adhesive. When mixed 
with n-butyl cyanoacrylate in concentrations of 2% agents (page 147) 
numbers 2,3,4,5,8,10 were soluble with the cyanoacrylate and no 
destabilization occured. Agents number 6,7,9 were not soluble and caused 
polymerization. 
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All the. fluorescent agents numbers 1 to 10 mixed with the 
cyanoacrylate. When examined under UV light at 254 nm and 365 nm 
showed an effective level of fluorescence. The soluble fluorescent 
agents examined appear to lose their fluorescence due to chemical 
attenuation in combination with the cyanoacrylate. They are therefore 
considered unsuitable as indicators for tissue adhesive. 
Concentrations of agentsl to 10 in amounts over 2% destabilized 
the cyanoacrylate causing polymerization. Of the fluorescent agents 1, 
to 10 examined separately on glass using the same UV light only Anthracene, 
Acenaphthene and Phenanthrene gave any significant fluorescence. Again, 
the level of fluorescence was considered insufficient to provide the 
contrast indication required for surgical application. 
Fluorescent agent number 11, Sodium fluorescein, an established 
fluorescent in ophthalmic surgery, did not mix with cyanoacrylate. Agent 
Pylam LI-900 is a bright yellow compound. When mixed with cyanoacrylate 
in 2% concentration this agent was soluble and conferred its distinct 
yellow colour to the cyanoacrylate, no destabilization occurred. 
When irradiated by UV light at 254 nm and 365. nm an intense fluo- 
rescence resulted. Examined separately on glass under. UV light agent LI-990 
produced the same level of bright fluorescence. The agent is currently 
used for industrial fluorescent applications. In vitro studies of this 
agent are continuing. Fluorescent agent Natmer LI-1158, again an industrial 
fluorescent, was not completely soluble with the cyanoacrylate in a 2% 
concentration. This agent gave an acceptable fluorescence both in its 
powder form and when mixed with the cyanoacrylate. 
191 
Of the fluorescent agents examined in this study only LI-990 
is considered satisfactory regarding solubility, fluorescence and 
stability. Further toxicity studies of this agent are indicated to 
establish its future in medical application. 
During the investigation of sterilization methods, photo- 
sensitisation of cyanoacrylate by protoporphyrin IX dimethylester was 
used experimentally. Protoporphyrin IX dimethylester was soluble with 
n-butyl 413 cyanoacrylate mixed as a concentration of . 001%. When 
irradiated by UV light at 365 nm the cyanoacrylate fluoresced strongly 
orange-red. 
Survey 
From the total number of questionnaires sent out (1,034) 
Plastic Surgeons (289), Oral and Maxillo-Facial Surgeons (745), the 
response was Plastic Surgeons 60.2% and Oral and Maxillo-Facial 
Surgeons 46.0%. The results are presented in Table 13 a&b. 
more (4'4.77/ 
It is of interest to note that plastic surgeons used cyano- 
acrylate tissue adhesive. -ore pa-33 44-2%-than the oral surgeons - 
18.8% (Fig. 66). In view of the complexity of oral and maxillo-facial 
Pre 
ue, % ' Miy; % 
r. 
surgery and the rneel? A4na" use of biomaterials in dentistry it -eetr±- 
ý0. 
ve %ee-n +L t" or uteri 
be assumed that the oral surgeons would of tissue 
adhesive. 
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SURGICAL USE OF ADHESIVE SURVEY 
Plastic Svgeons Oral and Maxllo-Facial Svgsons 
Number Percentage Number Percentage 
Questionnaires sent out 289 745 
Returned completed 159 325 
Returned unanswered 15 60.2 18 
} 
46.0 
Ref. Q. 1. 
Based on completed questionnaires 
Do not use adhesive 88 55.3 264 81.2 
use adhesive 71 44.7 61 18.8 
Ref. Q. 2. 
Based on those using adhesive 
Used less than once a year 11 15.5 13 21.3 
Used 1-12 times a year 37 52.1 44 72.1 
Used 13-52 times a year 19 26.8 2 3.3 
Used 53 or more times a year 4 5.6 1 1.6 
No reply 0 0 1 1.6 
Ref. Q. 3. 
(includes those who use more than 
one adhesive) 
Use Histoacryl 64 90.1 44 72.1 
Use Henkel 1 1.4 0 0 
Use unknown brand 6 8.5 14 23.0 
Use other 8 11.3 4 65.6 
Did not answer 0 0 1 1.6 
Ref. Q. 4. 
(Includes those using adhesive for 
more than one purpose) 
Used for skin raft fixation 65 91.5 18 29.5 
Used for wound closure 6 8.5 16 26.2 
Used for fixation of dressings 15 21.1 19 31.1 
Used for other 11 15.5 33 54.1 
Ref. Q. 5. 
Had problems applying adhesive 29 40.8 27 44.3 
Did not have problems applying 
adhesive 41 57.7 33 54.1 
Don't know or no reply 1 1.4 1 1.6 
Table 13(a) 
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SURGICAL USE OF ADHESIVE SURVEY 
Plastic Surgeons Oral and Maxjo-Facial S& 
Number Percentage Number Percentage 
Ref. Q. 6. 
(a) Those who had problems 
applying adhesive 
Total number 29 27 
Said a precision applicator 
would help 25 86.2 23 85.2 
Said a precision applicator 
would not help 3 10.3 4 14.8 
Did not know 1 3.4 0 0 
(b) Those who did not have 
problems applying adhesive 
Total number 33 41 
Said a precision applicator 
would help 25 75.8 19 46.3 
Said a precision applicator 
would not help 
Did not know 
No reply 
6 
2 
0 
18.2 
6.1 
0 
16 
4 
2 
39.0 
9.8 
4.9 
Ref. Q. 7. 
Based on those NOT using adhesive 
Would consider using superior 
adhesive 70 79.5 206 73'0 
Would not consider using 
superior adhesive 11 12.5 23 8.7 
Did not know 2 2.3 0 0 
Did not answer 5 5.7 35 13.3 
Would consider using superior 
adhesive 66 93.0 61 100.0 
Would not consider using 
superior adhesive 3 4.2 0 0 
No reply 2 2.8 0 0 
Table 13(b) 
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The main type of tissue adhesive used by both groups of surgeons 
was Histoacryl. This can be attributed to adhesive being the only medical 
grade tissue adhesive on the market at the present time with a Medicines 
Commission product licence in the United Kingdom. * 
Surgeons of both groups used unknown brand cyanoacrylate. Again 
both groups used other cyanoacrylates but did not specify the adhesive as 
asked in the questionnaire (Fig. 67). 
Plastic surgeons predominantly used cyanoacrylate tissue adhesive 
to attach skin grafts. The oral surgeons used the adhesive more for wound 
closure and the fixation of dressings together with other unspecified 
applications in the oral and maxillo-facial area (Fig. 6 g). 
The indication from both groups was that a precision method of 
application would be of benefit and that a superior cyanoacrylate tissue 
adhesive was required and would use it if available. 
All the surgeons who returned the questionnaire said they 
would be interested in knowing the results of the survey. Both groups 
of surgeons provided constructive and complimentary comments to the 
questionnaire. The comments indicated considerable interest and support 
for the study and for future developments. 
*United Kingdom Product Licence No. 3551/0001 
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Review of patients from the Bradford fire 
The three year review of those patients who had skin grafts 
attached by means of n-butyl 413 cyanoacrylate following extensive 
burns showed satisfactory results. From examination of the 15 patients 
it was confirmed that the grafts attached with n-butyl cyanoacrylate 
were comparable with skin grafts attached by conventional methods. 
The review demonstrated the benefits of this method of graft attach- 
ment. In emergency and life-saving surgery the use of cyanoacrylate 
functioned effectively providing good adhesion. No cases of premature 
termination of adhesion were seen in this study. The n-butyl 413 
cyanoacrylate combined relatively low histotoxicity and adhesive 
strength coupled with haemostasis. Only minimal amounts of the adhesive 
are required for effective graft attachment. Precision controlled 
dispensing ensured optimal results. No adverse medical history was 
noted relating to the tissue adhesive used. 
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After all, when the historians of Science look back on our times 
with the perspective of the years, all that we do today will 
certainly be seen to have been wrong, irrelevant, or obvious. 
G. H. Herbig 
In Star Formation 
Reidel 1977 
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GENERAL CONCLUSIONS 
ý"i 
The need for prosthetic reconstruction and the use of bio- 
materials in the form of prostheses and devices have become an estab- 
lished method of treatment in keeping with advances in medical science. 
More people are now surviving disfiguring injuries and disease which 
would formerly have claimed there lives. There is a growing awareness 
of plastic and reconstructive surgeons in the value of facial and body 
prostheses and the advantages of this form of rehabilitation.. 
Despite the-important contribution of this field to plastic 
surgery, facial prosthetics has remained the Cinderella of prosthetics. 
Little attention has been directed to the development of new materials 
and techniques. The importance of specifically structured materials 
cannot be over-emphasized. - 
This study has examined the materials available with particular 
reference to the use of silicone-elastomers for prosthetic reconstruction. 
Six cu'renHy used 
The physical properties of/six currently used silicone elastomers were 
subjected to mechanical testing to define the optimum properties required 
for-facial"prosthesis. -Variation of the ratios of polymer to catalyst 
were examined to determine modulus variations in. the elastomers. 
A facial prosthesis-does not require to be of the same 
rigidity throughout its full anatomical form. Differing areas of flex- 
ibility in the ear and nose are examples. The orbital region may need 
an extra flexibility to utilize the topography of a defect. The 
elastomers were tested to determine comparative effects of fillers to 
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exploit the various hardness values. This consideration is of import- 
ance in supporting areas of a prosthesis. The effects of different 
methods of vulcanization of the elastomers examined can determine tear 
strength. This data relates to durability of a prosthesis and its 
term of use by the patient. The qualitative pigments which constitute 
the colouring of human skin have been simulated by organic pigments to 
form skin shade variations in the elastomers. 
The pigments must remain stable during vulcanization and exposure 
to the environment. Clinical experience in this study confirms that pig- 
ments could be further improved by continued research into colour stability, 
together with chemical reaction between pigments and catalysts. 
Of the elastomers examined SILSKIN has been established as the 
most satisfactory. The physical properties and performance during mechanical 
testing was less than the elastomers Polyshield and HV 25. However, 
the tensile, modulus and tear strength is considered acceptable for general 
prosthetic use. SILSKIN has been extensively used for our patients. 
A particular advantage of SILSKIN is its ease of pigmentation and manage- 
ment in both clinical and laboratory procedures. The material is now 
Marke Fed 
used extensively in the National Health Service and. -produced_in a lab- 
oratory kit for international use by a U. K. medical company. * 
p 
The clinical development of osseointegration implant techniques 
pioneered by BRAMEMARK are-now being applied to retention and attachment 
of facial prosthesis. This-skin penetrating implant is only successful 
*Chas. F. Thackray Ltd., Leeds, West Yorkshire. 
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if the facial prosthetic material used as the superstructure has the 
physical properties quantified in this study. The same material criteria 
apply to the prosthesis used in the subcutaneous Samarium-Cobalt magnets 
developed by SWARTZ and TSUTSUI. 
Patient selection for osseointegration attachment of facial 
W 
prosthesis is of particular importance. Consideration should be given 
to the advantage gained in relation to the surgery and possible problems that 
can result. In most patients effective attachment and retention can be 
achieved by use of correctly matched prosthetic adhesive in relation-to 
the prosthetic elastomer used. The attachment of prostheses and devices 
continues to increase throughout the medical area. The prosthetic 
adhesives currently available are limited mainly due to the problems of 
biological adhesion and the diverse range of polymers used for prostheses. 
There is now an impetus to develop new external adhesives to function 
effectively in a biological environment, with reference to the prosthetic 
material to be attached to the skin. 
No single adhesive will be completely successful in all loc- 
ations under all conditions. The same observations can be made in 
respect to more conventional industrial applications of adhesive. This 
study indicates the selection and match of prosthetic adhesives to obtain 
the best performance in topical adherence with a reasonable time duration. 
Patients find handling characteristics important. Clinical experience 
has shown that a simple to apply adhesive which functions well is more 
successful than complicated mechanical methods of attachment. 
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The use of cyanoacrylate as a tissue adhesive as an alter- 
native to conventional skin suture has many advantages. The use of 
cyanoacrylate in the Vietnam War drew attention to the potential of tissue 
adhesive. Major fire disasters in the UK have also demonstrated the 
effective use of cyanoacrylate tissue adhesive and most of the surgical 
disciplines report its use in specific appliations. 
It has been established that n-butyl cyanoacrylate is the most 
tissue tolerated of the cyanoacrylates applied to surgery. In this study 
a formulation of a n-butyl cyanoacrylate has been developed in collabor- 
ation with LOCTITE UK. The current status of the adhesive n-butyl 413 
meets the clinical criteria regarding minimum histotoxicity and persisting 
adhesion and has been successfully used at this centre for skin graft 
attachment. 
One of the main disadvantages of the use of cyanoacrylate in 
surgery has been the difficulty of its application. To overcome this 
problem a precision applicator has been developed jointly with LOCTITE UK. 
The applicator enables the surgeon to have precision control of the tissue 
adhesive. The first model of the applicator drew on industrial experience 
for adhesive dispensing. The pressure system was provided by compressed 
air and a pressure reservoir. This was most effective but required 
calibration and intricate tubing. In a modified development the pressure 
source was obtained from a CO2 sparklet bulb to make the system less 
dependent on bottle or mains air supply. 
The current model uses a peristaltic pump to provide the 
pressure required and a simple tubing system is employed which allows 
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the precision applicator to be quickly set up and functional. The 
UV light option gives the applicator an additional facility, as fluorescent 
agents are defined for the adhesive. The applicator has now eliminated 
the handling difficulties of cyanoacrylates in the operating theatre. 
It has considerable potential in military surgery. A rechargeable or 
. battery unit used to drive the peristaltic pump would make the applicator 
a useful instrument for battlefield surgery. A similar use can be found 
for the applicator in veterinary surgery. 
Clinical trials of the applicator have been most successful. 
Surgeons and theatre staff complement its use. It is proposed to market 
the precision applicator with the proposal that it becomes an accepted 
instrument in the modern operating theatre. 
The survey of surgeons confirmed the interest and need for an 
improved adhesive and 
'a 
more satisfactory method of its application. 
The general interest of surgeons in the use. of tissue adhesives and 
the increasing requests for information and assistance with surgical 
problems have encouraged this research. 
Cyanoacrylates have made a distinct contribution as tissue 
adhesives. Continued study and further clinical experience will con- 
firm their; ultimate place in surgery. 
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SUGGESTIONS FOR FURTHER WORK 
The physical and mechanical properties investigated in 
facial prosthetic elastomer could be further extended by considering 
the effects of pigment concentration on mechanical properties. Colour 
P stability of pigments following differing methods of vulcanization 
together with ageing effects also need further investigation. 
Room temperature vulcanizing silicone elastomers considered 
at present to have limited application in facial prosthetics need 
their physical and mechanical properties improved. This group of 
elastomers with enhanced properties would have considerable potential 
in the treatment of patients by further development of RIV systems. 
Photochromatic pigments now available would be an effective 
method of skin colour compensation in differing environments. Investig- 
ation of these pigments as surface coatings on silicone elastomers would 
improve aesthetics in facial prosthetics. 
Colour analysis by spectrophotometric measurement is now an 
established science: Hand held instrumentation for clinical use would 
enable a computed data base to be established of human skin colouring, 
providing mathematical colour simulation. 
In examination of the literature and from animal and human 
studies there is considerable morphological evidence available con- 
cerning cyanoacrylates. Further histology now needs to be completed 
regarding the process of degradation. The hypothesis that histo- 
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toxicity is in part due to degradation into formaldehyde and cyano- 
acetate derivatives requires confirmation. Dr. Valerie Randall, of 
the University of Bradford has established a tissue culture system for 
skin cells and hair follicles, it is proposed to further test n-butyl 
413 cyanoacrylate formulated for tissue bonding by this system. 
=01 
Sterilization of cyanoacrylate by photosensitization methods 
indicated in this research by the use of protoporphyrin IX dimethyl- 
ester signify a considerable advance in sterilization technology. This 
method of sterilization could be used for other pharmaceutical compounds 
and requires further development. 
The advantage of incorporating a fluorescent agent into cyano- 
acrylate tissue adhesive for UV light indication has been described. 
Research is required into the toxicity and chemistry of 
fluorescent agents for medical use, in particular fluorescent agent 
L1-990. Heamostasis by topical application of bio-materials is developing 
in surgery. Heamostasis following topical application of cyanoacrylate 
occurs rapidly, this phenomenon is not fully understood. Investigation 
by electron microscopy may contribute to further understanding. 
The use of cyanoacrylate as a tissue adhesive commends itself 
to veterinary applications. The problem of tissue closure and bone 
fixation in an uncooperative animal in a difficult environment would 
suggest a role for tissue adhesive. Clinical trials in veterinary 
surgery are indicated. 
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The Medical Bondmatic II applicator now designed to function 
efficiently with a paristaltic pump could be further developed by 
supplementing the electricity mains power supply with a battery power 
unit. The facility of both battery or mains power mode would further 
extend the use of the Medical Bondmatic II applicator. A mains power 
rechargeable unit could also be a design feature for future models of 
the Medical Bondmatic applicator. 
10, 
. rw 
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Appendix 
MICROBIOLOGY LABORATORY REPORT 
Sterility Test n-butyl 413 Cyanoacrylate Tissue Adhesive 
Introduction 
Three specimens of n-butyl Cyanoacrylate 20CP were 
submitted to the Department of Microbiology, 
Leeds General Infirmary, to test and check sterility 
(14.9.88). 
Sample No I1x 50m1 pyrex glass conical beaker containing 
20m1 n-butyl 413 Cyanoacrylate. The specimen was 
sterilised by dry heat as described 
(Page 147: sterilising procedures). 
Sample No II 1x 20gram polyethylene bottle containing 20ml 
n-butyl 413 Cyanoacrylate. The specimen was 
sterilised by gamma irradiation as described 
(Page 147: sterilising procedures). 
Sample No III 1x 20gram polyethylene bottle containing 20m1 
n-butyl 413 Cyanoacrylate. The specimen was not 
sterilised and was as supplied clean by Research 
and Development Division, Loctite. No sterilisation 
procedures had been used. 
Laboratory Procedure 
(16.9.88) 
Samples were taken using a sterile dry swab from the 
liquids in the three containers. Samples were also 
taken from the tops of the containers. 
The swabs were plated onto chocolate plate C02 agar and 
blood plate anaerobic agar. 
The plates were cultured for 48 hours at 370C. 
All samples were found to be sterile. 
